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ABSTRACT 
 
Background: Guideline-concordant therapies for survivors of an acute coronary 
syndrome (ACS) hospitalization require healthcare access, something that 
millions of Americans lack.  
Methods and Results: Using data from a prospective cohort study of over 2,000 
survivors of a hospitalization for an ACS in central Massachusetts and Georgia 
from 2011 to 2013, the first two aims of this thesis sought to identify the post-
discharge consequences for survival and health status of having: 1) financial 
barriers to healthcare, 2) no usual source of care, and 3) transportation barriers. 
We found that patients lacking a usual source of care and having a transportation 
barrier were more likely to have died within two years following hospital 
discharge compared to those without such barriers. Also, patients with financial 
barriers to healthcare were more likely to experience clinically meaningful 
declines in physical and mental health-related quality of life over the six months 
after hospital discharge. The third aim sought to better understand factors 
influencing the success of care transitions home after an unplanned 
hospitalization through a qualitative study of 22 patients. Participants described 
how adequate healthcare access, particularly having insurance and 
transportation to clinical appointments, facilitated the receipt of follow-up care 
and adherence to treatments.  
  
	
vi 
vi	
Conclusions: Limitations in healthcare access may contribute to poorer survival, 
health-related quality of life, and survival. Additional research is needed to 
identify interventions to improve healthcare access and test whether improved 
access leads to better patient outcomes.  
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CHAPTER I: INTRODUCTION 
 
The acute coronary syndromes (ACS), consisting of acute myocardial 
infarction (AMI) and unstable angina (UA), continue to be a leading cause of 
morbidity and mortality in the US.1 Patients who survive a hospitalization for an 
ACS are at an increased risk for complications that may result in a subsequent 
hospital admission or death.2-4  Although this risk is substantial,5 contemporary 
patients discharged from the hospital after an ACS have better chances of 
surviving and thriving than those in the past due, in part, to decades of progress 
in the understanding and treatment of coronary disease.6,7  
 Since the early twentieth century, treatment for an ACS has advanced 
from long-term bedrest to sophisticated reperfusion interventions and 
pharmacotherapies.6  In the 1950s, the development of coronary angiography 
permitted physicians to identify the occlusive, atherosclerotic lesions precipitating 
an ACS.6  This led to the development of techniques to restore coronary blood 
flow including coronary artery bypass grafting (1960s), thrombolytic therapy 
(1970s), balloon angioplasty (1970s), and intraluminal stenting (1980s).6,8 Better 
understanding of cardiac physiology led to medical therapies to increase 
myocardial perfusion and reduce the oxygen demands of the heart. These 
treatments helped to further decrease in-hospital and post-discharge mortality 
after an ACS.6 Cohort studies, such as the original and offspring Framingham 
Heart Studies, provided insights that would lead to the development of additional 
medical and lifestyle interventions to improve secondary prevention of coronary 
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disease.9,10 Never before have clinicians possessed so many effective means to 
treat patients with an ACS.  
 
Delivering optimal therapy to patients both during and after a hospitalization for 
an ACS, however, is costly. Estimates of the average cost for a hospitalization for 
an ACS range from $9,000 to $64,000.11 Pharmacotherapy for a patient’s 
underlying coronary heart disease during the year after experiencing an ACS can 
average $3,000.11 A full course of cardiac rehabilitation, which can greatly reduce 
the occurrence of cardiovascular disease-related mortality, can also cost 
thousands of dollars and impose substantial out-of-pocket costs on patients.12,13 
In addition to having means to pay for healthcare, patients may require additional 
resources such as having transportation to appointments and a usual source of 
care to coordinate treatment.14,15 Successful treatment of an ACS and underlying 
heart disease may heavily depend on a patient’s healthcare access.   
 What happens to patients with poor healthcare access following an ACS? 
Answering this requires a definition of healthcare access. The Institute of 
Medicine defines healthcare access as “the degree to which individuals and 
groups are able to obtain needed services from the medical care system.”16 
Levesque and colleagues have more expansively defined it as “the opportunity to 
identify healthcare needs, to seek healthcare services, to reach, to obtain or use 
healthcare services and to actually have the need for services fulfilled.”17  These 
definitions suggest that a wide range of factors affect access. A variety of 
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frameworks describing healthcare access differ on the actual dimensions of 
healthcare access, particularly with regards to the degree to which healthcare 
access reflects characteristics of healthcare organizations as opposed to the 
population seeking these services.17,18 In a contemporary systematic synthesis, 
Levesque and colleagues proposed a framework of healthcare access that 
incorporated most, if not all, of the elements of prior access models.17 In their 
view, access arises from the interplay between healthcare providers (e.g., the 
supply aspect of healthcare) with characteristics of the consumer (i.e., the 
demand aspect of healthcare).17 Healthcare access results from five aspects of 
providers: approachability, acceptability, availability/accommodation, affordability, 
and appropriateness; these provider aspects interact with consumer abilities to 
perceive the need for healthcare, to seek and reach healthcare, to pay for 
healthcare, and to engage with healthcare providers.17 “Healthcare access” is 
facilitated by expansive and complex interactions between patients and 
healthcare-systems.  
 While the US has the highest per capita spending on healthcare in the 
world, contemporary national, state, and local survey data show that millions of 
persons in the US experience substantial deficits in healthcare access.19 A 
complete elaboration of every such deficit falls beyond the scope of this thesis. 
We describe three healthcare access deficits relevant to patients with an ACS: 
having financial barriers to healthcare, lacking a usual source of care, and 
possessing transportation barriers to care. These barriers to healthcare access 
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are examined in relation to various post-discharge outcomes among hospital 
survivors of an ACS.  
 Financial barriers to healthcare result from the mismatch between the cost 
of healthcare services with consumers’ capacities to pay for those services.20 
Factors contributing to the expense of healthcare in the US include an 
underinvestment in preventative care, absence governmental price-controls, lack 
of integration, high administrative costs, financial compensation for services 
rather than outcomes, consolidation among health-care related entities, and 
delivery of unnecessary services.21 Meanwhile, Americans have increasingly 
greater demands for healthcare partly due to the aging of the population and the 
higher prevalences of chronic diseases.22 In 2014, an estimated 11.5% of 
Americans lacked insurance coverage and 5.3% could not get healthcare due to 
cost.23 In general, Americans lacking insurance are more likely to utilize 
emergency services, not take medications prescribed by their physicians, and 
experience declines in their overall health status.24   
 Patients who have difficulty paying for care may experience unfavorable 
outcomes following a hospitalization for an ACS. Several cohort studies show 
that patients without insurance, and those who are underinsured, or report overall 
difficulty paying for care typically have worse long-term mortality after surviving 
an ACS than those with better financial resources.20,25-28 They may experience 
worse health-related quality of life in the months following a hospitalization for an 
ACS than their peers with better access.20,29,30 Despite these collective findings, 
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there are limitations to their interpretation and generalizability, as they tend to be 
historical and failed to adjust for other barriers to healthcare, such as lacking 
transportation or a usual source of care. Professional society guidelines direct 
clinicians to evaluate patients’ financial status and health insurance coverage 
when preparing for discharge during a hospitalization for an ACS.31,32 However, 
there does not presently exist standardized, evidence-supported protocols for 
screening and addressing financial barriers to care in this population. This may 
be partly due to a lack of evidence about the role of financial barriers beyond just 
lacking insurance, as well as the lack of research performed as to how such 
barriers may influence changes in patient’s health status over time. Further clarity 
on the role of financial barriers after an ACS may be necessary to develop 
effective interventions tailored to patients’ ability to pay for care.  
 In addition to being able to pay for healthcare, patients typically require a 
usual source of care, “a place where an individual most often goes if he or she is 
sick or needs personal health advice, such as a doctor’s office, clinic, or health 
center.”14 In general patient populations, a usual source of care can ensure that 
patients’ receive appropriate healthcare.33,34 In the US, patients without a usual 
source of care are at risk for receiving poor care,35 having untreated hypertension 
or hypercholesterolemia,36 and using emergency departments for ambulatory 
healthcare needs.37,38 Moreover, a usual source of care is often necessary for 
directing patients to appropriate health resources in the complicated US 
healthcare system.39 Even patients with insurance may be unable to receive care 
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from specialists without referral from a usual source of care, typically a primary 
care provider.40 National survey data, however, indicates that 12% of the U.S. 
non-institutionalized population did not have a usual source of care in 2014, with 
even higher proportions among African Americans and Hispanic populations.23 
Although low income and a lack of health insurance may predispose an individual 
to lack a usual source of care,41 many persons without  a usual source of care do 
possess health insurance.41 Although some patients identify emergency 
departments (ED) as a usual source of care, EDs are generally not considered 
an acceptable usual source of care due to their high costs and prioritization of 
acute care.34 
 Current guidelines for treating patients with an ACS direct clinicians to 
arrange outpatient follow-up with a primary care provider, a typical usual source 
of care, following hospital discharge.32  Since a usual source of care provider 
often has an established, longitudinal relationship with a patient, they may have 
the best capability to ensure that a patient best manages his or her medical 
condition, particularly in the setting of other comorbidities.34 Their follow-up care 
may be particularly important given how common it is for patients to be 
discharged from the hospital with medication mistakes and pending studies.42-44 
There exists little data, however, on the consequences of  lacking a usual source 
of care among patients discharged from the hospital after an acute coronary 
event. Among the 2,454 patients who survived a hospitalization for an AMI in 
2003-2004 in the PREMIER study, those without a prior usual source of care had 
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all-cause death rates at 6 and 12 months that were 3.0 and 1.9 times, 
respectively, greater than patients reporting a strong usual source of care.14  
Insights on the role of this under-studied, but highly prevalent, health access 
issue among survivors of an ACS may help inform more optimal management 
practices, particularly since healthcare organizations may have the ability to 
provide a usual source of care should one be lacking.  
 Another important component of access to healthcare is the ability to 
reach healthcare providers.17 Few patients live within walking distance of their 
healthcare provider, or receive in-home or in-facility visits from providers; the vast 
majority of Americans typically travel via private automobiles to receive 
healthcare.45 Not only can owning a vehicle be costly, but many Americans may 
lack the ability to drive due to disability or medical restrictions.45 Hiring 
transportation may be prohibitively expensive, particularly if a clinic is far away 
and if patients require multiple visits over a short period of time. While many may 
use a social support network, including family and friends, to secure 
transportation,45,46 an increasing number of Americans report social isolation and 
may not be able to obtain such help. While states and insurers may provide non-
emergency transportation to certain populations, such services may be difficult to 
utilize and can be unreliable.47  
 To date there has been little study on the role of transportation access on 
patient-related outcomes after a hospitalization for an ACS, but circumstantial 
evidence suggests that a lack of transportation may lead to worse patient 
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outcomes. Post-discharge outpatient care, including follow-up visits with primary 
care providers and cardiologists as well as cardiac rehabilitation, may lead to 
better treatment and patient adherence that could result in better health-related 
quality of life and lower mortality.13,48,49 Survivors of an ACS underutilize both 
follow-up care and cardiac rehabilitation,14,50 thereby foregoing its benefits, and 
the inability to obtain transportation may contribute to this underutilization.15,50,51 
Moreover, survivors of an ACS are at high risk of developing an acute 
complication or sequelae of their heart disease, such as a recurrent ACS, that 
would require prompt medical attention and hospitalization.3,5  While most 
Americans have access to emergency medical transportation that will deliver 
them to an emergency room for evaluation regardless of their ability to pay,52,53 
many choose not to use it, even when appropriate due to concerns about costs 
and feelings that their symptoms may not warrant treatment.54 A lack of 
transportation among survivors of an ACS could delay treatment seeking when 
one experiences acute complications and thereby worsen morbidity and 
mortality. However, the extent to which transportation barriers may influence 
overall health and survival over the months and years following a hospitalization 
for an ACS remains unknown. Since clinicians can readily screen for 
transportation barriers in their patient populations, and may be able to arrange for 
reliable transportation services, better study of the role of transportation barriers 
is particularly warranted given its role as a potentially modifiable risk factor.  
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 In summary, advances over the past several decades in lifestyle 
interventions and medical treatments for both an ACS and underlying coronary 
heart disease have reduced morbidity and mortality. The current structure of the 
American healthcare system, however, makes the delivery of healthcare 
expensive and difficult. The millions of Americans who have suboptimal access 
to healthcare due to factors such as financial barriers, having no usual source of 
care, and inadequate transportation may have worse outcomes after surviving a 
hospitalization for an ACS. Both policymakers and clinicians face increasing 
pressure to address barriers to healthcare access as demand for healthcare 
services will continue to increase. Better understanding of how barriers to 
healthcare impact patient outcomes will be invaluable for both groups. 
Nevertheless, despite both the high incidence and costs associated with 
treatment for an ACS, there exists little data describing the role of healthcare 
access to the post-discharge outcomes of patients who survive a hospitalization 
for an ACS.  
 This thesis will address the substantial knowledge gap about the role of 
barriers to healthcare access on post-hospital outcomes of survivors of an ACS 
using data from the Transitions, Risks, and Actions in Coronary Events Center 
for Outcomes Research and Education (TRACE-CORE) longitudinal cohort study 
of more than  2,000 survivors of an ACS discharged from six hospitals in central 
Massachusetts and Georgia.55,56 To better understand patients’ perspectives on 
how barriers to healthcare may influence care transitions after an unplanned 
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hospitalization, this thesis contains a qualitative study of 22 interviews with 
patients, including survivors of an ACS, from a PCORI-funded project to develop 
and validate a new measure of patient perceptions of the quality of transitions 
care from the hospital to outpatient setting. The discussion of this thesis will 
contextualize its findings in the ongoing national debate over healthcare policy. 
The specific aims of the thesis are:    
 
Aim 1. Using data from the TRACE-CORE study, determine if patients with 
barriers to healthcare access at the time of hospitalization for an ACS have 
higher all-cause mortality within two years of discharge compared to patients with 
good healthcare access.  
 
Aim 2: Using data from the TRACE-CORE study, determine if patients with 
barriers to healthcare access at the time of hospitalization for an ACS are more 
likely to experience clinically meaningful declines in health-related quality of life 
than their peers with better healthcare access during the six months after hospital 
discharge.  
 
Aim 3: Through a qualitative study of patients with a recent unplanned 
hospitalization, examine patients’ perceptions of how barriers to healthcare 
access, in conjunction with other factors within and outside of the medical 
system, influence the success of their transition to the outpatient setting.
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CHAPTER II: BARRIERS TO HEALTHCARE ACCESS AND LONG-TERM 
SURVIVAL AFTER HOSPITAL DISCHARGE FOR AN ACUTE CORONARY 
SYNDROME 
 
 
ABSTRACT 
Background: Barriers to healthcare remain common in the US and may result in 
worse outcomes among hospital survivors of an acute coronary syndrome (ACS). 
We examined the relationship between barriers to healthcare and two-year post-
discharge mortality among hospital survivors of an ACS.  
Methods: Hospital survivors of an ACS were recruited from 6 medical centers in 
central Massachusetts and Georgia in 2011-2013. Participants reported whether 
they currently had a usual source of care as well as a financial or transportation 
barrier in the year prior to admission. Cox regression analyses calculated hazard 
ratios (HRs) for two-year all-cause mortality for the three individual healthcare 
barriers while adjusting for demographic, clinical, and psychosocial 
characteristics. 
Results: The mean age of study participants (n=2,008) was 62 years, 33% were 
women, and 77% were non-Hispanic white. One third of patients reported a 
financial barrier, 17% lacked a usual source of care, and 12% had a 
transportation barrier. Five percent (n=100) died within two years after hospital 
discharge. Compared to their counterparts without barriers, those lacking a usual 
source of care and with barriers to transportation had significantly higher 
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mortality (adjusted HRs 1.58, and 1.55, 95% CI: 1.15 to 2.09, respectively); while 
those having a financial barrier did not (adjusted HR 0.81, 95% CI: 0.49 to 1.33).  
Conclusions: Hospital survivors of an ACS lacking a usual source of care and 
with barriers to transportation may be at higher risk for dying after an ACS; these 
patients may require more intensive follow-up.  
 
 
INTRODUCTION 
Guideline-concordant medical, physical, and behavioral therapies can 
reduce mortality among patients who survive a hospitalization for an acute 
coronary syndrome (ACS).9,31,32 Utilizing these strategies requires both access to 
clinicians and means of financing healthcare. Survivors of an ACS may need 
costly pharmaceuticals and outpatient services in the year following hospital 
discharge, with total average costs ranging from $3,000 and $10,000.11,57,58 
National survey data, however, suggests that barriers to healthcare are common 
among Americans. In 2014, about 1 out of every 10 American adults reported 
lacking health insurance, a similar proportion lacked a usual source of medical 
care, and 1 out of 20 were unable to obtain needed care due to its cost.23 
Patients with poor healthcare access may receive suboptimal secondary 
prevention14,15 and be at greater risk for poor outcomes.24,59 
While current guidelines for the treatment of ACS advise clinicians to 
screen for barriers to healthcare, there lack definitive strategies to address 
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deficits in healthcare access.31,32 A limited number of studies have found an 
inconsistent relationship between different markers of poor access to healthcare, 
such as lacking a usual source of care or health insurance, with mortality 
following hospitalization for an acute myocardial infarction.20,26,60,61 A consistent 
limitation of these prior studies, however, has been the focus on only one form of 
healthcare barrier without adjustment for other forms of barriers. A better 
understanding of how barriers to healthcare impact mortality following a 
hospitalization for an ACS could help guide the development of interventions to 
patients with worse access to care.  
Using data from a prospective cohort of hospital survivors of an ACS,55,56 
we examined the association between financial barriers, no usual source of care, 
and transportation barriers to healthcare with two-year all-cause post-discharge 
mortality. 
 
METHODS 
Study Sample 
This study uses data from the Transitions, Risks, and Actions in Coronary 
Events Center for Outcomes Research and Education (TRACE-CORE) 
study.55,56 In brief, 2,174 adults hospitalized for an ACS were recruited from 3 
community and tertiary medical centers in Worcester, Massachusetts, 2 hospitals 
in a managed care network in Atlanta, Georgia, and a tertiary care hospital in 
Macon, Georgia between April 2011 and May 2013. Eligible participants were 
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≥21 years of age and were discharged alive from participating medical centers. 
Exclusion criteria included having an ACS secondary to another acute medical 
event (e.g., surgery), delirium, pregnancy, and receipt of hospice or palliative 
care. Trained research assistants abstracted data from patient electronic medical 
records (EMRs) for the index hospitalization, performed computer-assisted 
interviews with participants during the index hospitalization or by telephone within 
72 hours of discharge, and reviewed state vital records to assess mortality status 
at two years post-discharge. The institutional review boards at participating sites 
approved this study.  
The analytic sample (n=2,008) for the current study consisted of patients 
with an adjudicated classification of their ACS type and the three measures of 
healthcare access. We performed multiple imputation by chained equations to 
estimate the values of potentially confounding covariates for the 204 (10.2%) 
participants with missing data.62 
Measuring Barriers to Healthcare Access 
Prior frameworks have identified factors ranging from individual patient 
attitudes to geography as determinants of healthcare access.45 Using the 
Andersen Model of Access,63,64 we chose to examine three enabling factors 
(logistical barriers to accessing care) identified in TRACE-CORE: financial 
barriers, no usual source of care, and transportation barriers. 
Specific Barriers to Healthcare 
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For this study, we considered a financial barrier to healthcare as a lack of 
insurance coverage and/or self-reported difficulty affording healthcare. We 
determined insurance status according to EMR documentation. At baseline, 
interviewers asked participants “in the past twelve months, have you avoided 
obtaining any health care services because of the cost?” and/or “during the past 
12 months, have you had any problems paying medical bills?”20 We classified 
participants answering yes to either of these questions along with those lacking 
medical insurance as having a financial barrier. 
To determine the presence of a usual source of care, interviewers asked 
participants “is there a place that you usually go to when you are sick or need 
advice about your health?” Interviewers asked participants responding “yes” to 
classify the place as a clinic or health center, doctor’s office or HMO, emergency 
room, or outpatient department.23 We classified patients who reported no usual 
source of care and those who reported that their usual source of care was an 
emergency room as lacking a usual source of care.23  
To assess transportation-related barriers to healthcare, interviewers asked 
patients “within the past 12 months, have you missed a medical appointment or 
been unable to obtain needed health care because of problems with your 
transportation?” and “overall, and in terms of transportation, how difficult is it for 
you to get to your health care appointments?” (no problem at all, not very, 
somewhat, moderately, or extremely difficult). We classified patients who 
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reported missing an appointment in the prior year, or having moderate or 
extreme difficulty in getting to appointments, as having a transportation barrier. 
Multiple Barriers to Healthcare 
As a secondary analysis, we examined the relationship between 2-year 
all-cause post-discharge mortality with number of barriers to healthcare present. 
We lacked the statistical power to assess relationships between each potential 
combination of barriers with death. We instead categorized patients as having no 
barriers, 1 barrier, or 2 or more healthcare barriers. 
All-Cause Mortality 
Study coordinators reviewed state vital statistics records to ascertain 
patients’ survival status within the first two years after hospital discharge for their 
index ACS event. 
Potential Confounding Variables  
We examined several sociodemographic, clinical, and psychosocial 
characteristics as potential confounders between healthcare barriers and 2-year 
total mortality.  
Demographics 
Age and sex were abstracted from EMRs. During the baseline interview, 
participants reported their race and ethnicity, household composition, 
employment status, and level of education. We assessed financial strain by 
asking patients “in general, how do your finances usually work out at the end of 
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the month?” (some money left over, just enough to make ends meet, not enough 
to make ends meet).20  
Clinical Characteristics 
Trained reviewers abstracted data on participants’ medical history and 
hospital course from hospital records. To confirm and classify patients’ type of 
ACS as ST-segment elevation myocardial infarction (STEMI), non-STEMI 
(NSTEMI), or unstable angina (UA), two cardiologists reviewed ECG, cardiac 
biomarker, and cardiac catheterization data from medical records.65,66 Patients 
reported their smoking status (current, former, or never) at baseline. We 
calculated Global Registry of Acute Coronary Events (GRACE) risk scores (2.0) 
for mortality using data on age, cardiac biomarkers, ST segment changes, 
systolic blood pressure, creatinine or history of renal dysfunction, Killip class, use 
of diuretics, and the development of cardiac arrest during the patient’s index 
hospitalization.67 GRACE 2.0 scores are scaled from 0 to 263, with higher scores 
indicating a higher probability of death; the GRACE model has demonstrated 
strong predictive discrimination of mortality for periods of 1 and 3 years after 
hospital admission for an ACS.67 We divided GRACE risk scores into four 
categories after examining the distribution of deaths in our study population 
according to their GRACE risk score. 
 
Psychosocial Characteristics 
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Patients were categorized as having low-health literacy if they reported 
having little or no confidence when they were asked how confident they were in 
filling out health forms by themselves.68 To assess patient’s cognitive status, 
participants completed the 11-item Telephone Interview for Cognitive Status 
(TICS, range 0 to 41); we classified patients as being unimpaired (≥ 33), 
ambiguous (26 to 32), or moderate to severely impaired (≤ 25).69 We assessed 
depressive symptoms with the 9-item Patient Health Questionnaire (PHQ9, range 
0 to 27) and designated participants as having no (≤ 4), mild (5 to 9), or moderate 
to severe (≥10) depressive symptoms.70 We measured anxiety symptoms with 
the 7-item Generalized Anxiety Disorder questionnaire (GAD7, range 0 to 21) 
and designated participants as having no (≤ 4), mild (5 to 9), or moderate to 
severe (≥10) symptoms of anxiety.71  
Statistical Analysis 
We compared study participants’ sociodemographic, clinical, and 
psychosocial characteristics according to the presence of individual barriers to 
healthcare access using chi-square goodness of fit tests for categorical variables, 
and unpaired t-tests for continuous variables.  
To examine the association of healthcare barriers with all-cause mortality 
in the two years after hospital discharge, we calculated unadjusted and 
multivariable adjusted hazard ratios (HRs) with accompanying 95% confidence 
intervals (CIs) using adjusted and unadjusted Cox proportional hazard regression 
models.72 We inspected Schoenfeld residuals and log-log plots72 to confirm that 
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the key exposure variables and additional covariates satisfied the proportional 
odds assumption.  
We first examined the three specific barriers for care (e.g., financial 
barriers, lack of usual source of care, and transportation barriers) in the same 
regression model. Based on clinical judgement, we decided apriori to adjust for 
site, sex, race/ethnicity, GRACE risk score, and receipt of in-hospital reperfusion 
therapy as covariates. We included additional variables, including education, 
living situation, prior heart disease, prior peripheral vascular disease, chronic 
kidney disease, and depressive symptoms that we found changed the measure 
of association for one or more of the healthcare barriers with all-cause mortality 
by 10 percent or more. We did not include variables already accounted for in the 
GRACE risk score after preliminary analyses showed their incorporation did not 
improve model fit nor substantially change the main measures of association, 
with the exception of a history of chronic kidney disease. We used a clustered 
sandwich estimator to calculate the standard errors of coefficients to account for 
the potential lack of independence of outcomes of patients being treated at the 
same clinical site.73 We present all of the calculated hazard ratios for all the 
variables in the adjusted models in the appendices.  
We also constructed Cox proportional hazard regression models to 
examine the relationship between the number of healthcare barriers with all-
cause mortality. We used the same set of adjustment variables for this analysis 
as described above.  
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RESULTS 
Of the 2,174 TRACE-CORE study participants, we excluded those with 
missing information on type of ACS (n=53) and one or more of the health care 
barriers of interest (n=113) resulting in an analytic sample of 2,008. The sample 
mean age was 61.6 years (SD 11.3), 33.1% were women, and 76.7% were non-
Hispanic white; 15.0%, 55.7%, and 29.3% were diagnosed with STEMI, NSTEMI, 
and UA, respectively.  
One-third of participants (33.1%) reported a financial barrier, 17.1% lacked 
a usual source of care, and 11.9% reported a transportation barrier; 45.7% of 
participants had at least one of these three healthcare barriers (Table 2.1). 
Participants with each specific healthcare barrier were younger, on average, with 
smaller proportions reporting to be non-Hispanic white, a college graduate, living 
with a spouse, retired, or having no monthly financial strain compared to their 
counterparts who did not have the healthcare barrier of interest. Higher 
proportions of participants with each specific healthcare barrier were currently 
smoking and had a hospitalization of ≥ 3 days, but mean GRACE risk scores 
were lower than those without specific barriers. Low health literacy, mild to 
severely impaired cognitive status, moderately severe to severe symptoms of 
depression, and severe symptoms of anxiety were more prevalent among 
participants with specific barriers (p< 0.05 for all comparisons).  
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The crude all-cause mortality rates of the sample, both overall and 
according to the presence of specific barriers to healthcare, are presented in 
Table 2.2. After adjusting for several potentially confounding variables and other 
healthcare barriers, we identified statistically significant associations between 
higher rates of all-cause mortality with having no usual source of care (adjusted 
HR: 1.58, 95% CI: 1.24 to 2.01) and having a transportation barrier (adjusted HR 
1.55, 95% CI: 1.15 to 2.09). We observed no significant associations between 
having a financial barrier with all-cause mortality in crude and multivariable 
adjusted models (Figure 2.1). 
Figure 2.2 depicts a proportionate Venn graph showing the degree of 
overlap between barriers to healthcare together with crude all-cause mortality 
according to each possible combination of barriers. Overall, 1,090 patients 
(54.3%) had no barriers, 633 (31.5%) had 1 barrier, and 285 (14.2%) had 2 or 
more barriers with corresponding crude 2-year all-cause mortality rates of 4.9%, 
4.4%, and 6.7%, respectively. After multivariable adjustment, patients with two or 
more healthcare barriers were 1.53 (95% CI: 1.03 to 2.27) times more likely to 
have died with two years after discharge than those without any healthcare 
barriers to care (Figure 2.3). We did not find a crude nor adjusted association 
between having only one barrier to healthcare with higher all-cause mortality.  
 
DISCUSSION 
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In this prospective study of 2,008 survivors of an ACS almost one half 
reported barriers to healthcare access, including barriers related to affording 
care, having a usual source of care, and transportation. After adjusting for 
sociodemographic, clinical, and psychosocial characteristics, we found an 
association between barriers related to usual source of care and transportation 
with higher all-cause mortality over two years after hospital discharge. We did not 
identify an association between financial barriers to care and all-cause mortality, 
but those with two or more of these specific healthcare barriers were less likely to 
survive for two than those with no healthcare barriers. Having certain as well as 
more barriers to healthcare may be common among survivors of an ACS and 
impact long-term survival. 
Prevalence of Healthcare Barriers 
Our findings of a high prevalence of barriers to healthcare is consistent 
with results from regional and national studies of hospital survivors of an ACS. 
The Prospective Registry Evaluating Myocardial Infarction: Event and Recovery 
(PREMIER) study found that 18% of 2,498 participants reported avoiding 
healthcare due to costs in the year before hospitalization for an acute myocardial 
infarction (AMI) at 12 nationwide medical centers between 2003-04;20 another 
analysis of PREMIER participants found that a similar proportion lacked a usual 
source of care.14 A study of 4,908 patients hospitalized for AMI at three Maryland 
hospitals between 1993 and 2008 identified 16% of patients as being 
underinsured (i.e., lacking health coverage or having limited coverage).25 A 
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qualitative study of 14 patients with heart disease in Canada described how 
barriers to care, such as underinsurance and lack of transportation, can prevent 
patients from receiving optimal care by skipping follow-up appointments and 
taking their prescribed medications.15 The high prevalence of barriers to care in 
the present study and others suggest the importance of assessing healthcare 
access among survivors of an ACS, especially since ongoing contact with the 
medical care system may be required to receive optimal secondary prevention 
therapies.31,32 
Financial Barriers  
We did not identify an association between financial barriers to healthcare 
access and utilization with increased all-cause mortality during the 2 years after 
hospital discharge for an ACS. This may result from these patients utilizing 
emergency services that do not require payment and/or still being able to obtain 
inexpensive generic medications.34 In contrast, several studies have found 
positive associations of financial barriers to care with higher mortality among 
those with cardiovascular disease.20,25,74 In the aforementioned study of patients 
hospitalized for an AMI at three Maryland hospitals, the risk of dying from all 
causes over a 14 year follow-up period was 30% higher among underinsured 
patients compared with well-insured patients.25 Participants in the PREMIER 
study who reported avoiding medical care due to cost experienced all-cause 
mortality within a year of hospital discharge at a non-statistically significant rate 
40% higher than for those without such a barrier.20 Of note, a nationally 
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representative cohort of 120,752 patients with pre-existing cardiovascular 
morbidity in Canada, which provides universal health coverage, found that 
patients reporting any financial barrier to healthcare (including medication costs 
and indirect costs of care) had an all-cause mortality rate approximately one 
quarter higher than those who had no financial barriers.74  
Usual Source of Care 
The presence of a usual source of medical care may confer benefits to 
patients and the healthcare system by leading to better health screens,35,75 
optimal chronic disease treatment,36 and reducing the need for emergency 
care.37,38 After accounting for financial barriers to care and transportation access, 
we found a positive association between lacking a usual source of care and 
higher all-cause mortality. An analysis of 2,454 survivors of an AMI in the 
PREMIER study found that those lacking a usual source of care experienced all-
cause death rates at about double the rate of those with an established usual 
source of care during the year after hospital discharge.14 Lacking a usual source 
of care might result in patients having greater difficulty establishing outpatient 
follow-up and, interfering with secondary prevention for their underlying coronary 
artery disease.  
Transportation Barriers 
There exists little data on the relationship between barriers to 
transportation and post-hospital outcomes after an ACS. We identified a higher 
risk of dying among those with, as compared to those without, transportation 
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barriers. This may be a result of patients being unable to obtain adequate care 
for the secondary prevention of their heart disease due to transportation related 
concerns. A contemporary systematic review on the impact of transportation 
barriers in general patient populations suggests a lack of transportation is a 
leading cause of missed medical appointments and may prevent patients from 
obtaining prescription medications.76 Despite requirements for many Medicare 
and Medicaid plans to offer transportation services to patients, many patient 
transportation services have poor reliability and include excessive wait times.47 
Now that mobile technology platforms are offering novel and less expensive 
ways to obtain transportation, healthcare systems may soon have better ways to 
assist patients with transportation barriers.47 Further investigation is warranted to 
assess how ensuring adequate transportation access may improve both short 
and long-term clinical outcomes among patients discharged from the hospital 
after an ACS.  
Quantity of Healthcare Barriers 
Our secondary analyses suggest that patients with two or more specific 
barriers to healthcare may have a greater risk of dying following discharge from 
the hospital after an ACS. We recognize that these analyses presumed an 
equivalency of healthcare barriers, which has not been previously demonstrated 
to the best of our knowledge; however, we did not have sufficient power to 
examine the relationship of different combinations of barriers with all-cause death 
rates. Nevertheless, we believe it is important to recognize that theories of 
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healthcare access suggest that any one of several barriers may prevent patients 
from obtaining healthcare;17 just because a patient is free from one type of barrier 
does not mean that another barrier cannot prevent him or her from obtaining 
effective care. Indeed, efforts to evaluate and address the role of individual and 
absolute numbers of barriers to healthcare access and utilization will likely 
require multifactorial assessment. 
Study Strengths and Limitations  
The strengths of this multi-site prospective study include its large sample 
of patients with confirmed ACS. For several of our measures of healthcare 
access, we were able to pool the answers to related questions, reducing the risk 
of misclassification that could occur from using a single question to measure this 
construct. Nevertheless, we acknowledge several limitations. This study may lack 
generalizability in patient populations different than those at participating medical 
centers. As with all observational studies, despite the many potential 
confounders we adjusted for in our regression analyses, unmeasured 
confounding may have biased the associations observed. For instance, we could 
not account for the receipt of inpatient and post-discharge social services among 
those with barriers to care which may have attenuated the relationship between 
barriers to care and all-cause post-discharge mortality. Finally, since we only 
searched Massachusetts and Georgia death certificate records to confirm 
patient’s vital status, we could have missed deaths that occurred in other states.  
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CONCLUSION 
Hospital survivors of an ACS with barriers to a usual source of care and 
transportation exhibited higher all-cause mortality over two years following 
hospital discharge, suggesting that barriers to healthcare may contribute to 
poorer long-term health outcomes. Our findings suggest the need for clinicians to 
be aware of barriers to healthcare in devising patient’s treatment plans. 
Additional research to both confirm our findings in more generalizable 
populations, as well as determine ways for healthcare systems to best provide 
services for patients with barriers to care is warranted.  
.  
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Table 2.1: Baseline characteristics of survivors (n=2,008) of a 
hospitalization for an acute coronary, by presence of specific barriers to 
healthcare access  
  
Characteristics  
Full Sample 
(n = 2,008)  
Financial 
Barrier 
(n = 665)  
No Usual 
Source of 
Care 
(n = 343)  
Transportation 
Barrier 
(n = 239) 
Sociodemographic          
Age, mean, yrs (SD)  61.6 (11.3)  56.9 (10.2)  56.3 (11.6)  58.2 (10.9) 
Female (%)  33.1  39.7  30.6  42.7 
Non-Hispanic White (%)  76.7  68.4  64.0  59.8 
Education (%)         
  Less than high school  17.3  21.8  25.9  34.7 
  High school  29.7  35.0  36.4  28.5 
  Some college / post-high school   28.7  29.0  22.4  25.5 
  College graduate  24.2  14.1  15.2  11.3 
Living Situation (%)         
   With spouse  48.8  39.8  33.0  23.8 
   With family (non-spouse)  15.9  22.6  24.6  26.4 
   With non-family  13.5  14.5  17.8  17.2 
   Alone  21.9  23.2  24.6  32.6 
Employment Status (%)         
   Retired  39.0  24.4  20.2  30.4 
   Working  40.6  40.4  45.8  19.8 
   Unemployed  20.3  35.2  33.9  49.8 
Finances at End of Month (%)         
   Some left over  46.3  19.5  33.8  14.4 
   Just enough to make ends meet  34.4  40.3  34.7  36.4 
   Not enough to make ends meet  19.2  40.3  31.4  49.2 
Clinical          
GRACE score, mean (SD)*  95.9 (28.5)  88.7 (26.4)  88.7 (28.2)  95.1 (27.6) 
Prior Medical History (%)         
   Arthritis  20.1  17.1  14.9  23.0 
   Cancer  11.8  9.2  8.7  10.9 
   Chronic lung disease  18.2  20.5  20.4  26.4 
   Chronic kidney disease  11.3  9.9  11.4  18.4 
   Diabetes  33.0  38.8  30.3  48.1 
   Heart disease  52.9  56.7  50.4  69.0 
   Heart failure  14.2  16.5  13.1  24.3 
   Hyperlipidemia  69.2  68.0  58.6  70.7 
   Hypertension  76.2  76.7  69.1  85.8 
   Peripheral vascular disease  9.9  9.6  9.3  18.4 
   Stroke/TIA  9.3  8.6  9.3  13.8 
Smoking Status (%)         
   Never smoked  30.4  25.6  23.0  19.2 
   Former smoker  46.1  40.6  35.6  43.9 
   Current smoker  23.5  33.8  41.4  36.8 
ACS Type (%)         
   STEMI  15.0  10.7  13.4  10.0 
   NSTEMI  55.7  59.2  58.0  56.9 
   UA  29.3  30.1  28.6  33.1 
Reperfusion Therapy (%)         
   PCI  65.8  66.5  62.4  61.9 
   CABG Surgery  13.2  11.4  13.7  12.6 
   No PCI nor CABG  21.0  22.1  23.9  25.5 
In-hospital medications (%)         
   ACEI / ARB  61.6  63.6  61.2  65.7 
   Aspirin  96.5  95.8  97.1  92.9 
   Beta-Blocker  90.2  90.1  93.6  92.5 
   Lipid lowering medication  89.7  89.5  92.4  90.4 
Length of stay ≥ 3 Days (%)  52.1  54.6  58.0  63.2 
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Table 2.1 (continued) 
 
Characteristics 
 
Full Sample 
(n = 2,008) 
 
Financial 
Barrier 
(n = 665) 
 No Usual 
Source of 
Care 
(n = 343) 
 
Transportation 
Barrier  
(n = 239) 
Psychosocial          
Health Literacy (%)         
   High  63.7  58.2  58.0  46.4 
   Medium  17.8  18.9  18.3  25.5 
   Low  18.5  23.0  23.7  28.1 
Cognitive Status (%)         
   Normal  50.1  45.4  40.4  35.3 
   Ambiguous   42.8  45.4  47.6  48.7 
   Mildly or Severely Impaired  7.1  9.3  12.0  16.1 
Depressive Symptoms (%)         
   Absent  50.8  33.7  48.7  24.4 
   Minor  26.6  30.4  20.9  26.5 
   Moderate  13.4  18.0  15.2  23.1 
   Moderately Severe to Severe  9.1  17.9  15.2  26.1 
Anxiety Symptoms (%)         
   Absent  51.0  34.8  46.5  22.5 
   Mild  25.1  28.8  24.3  28.4 
   Moderate  12.6  16.2  12.3  22.9 
   Severe  11.3  20.3  17.0  26.3 
 
Abbreviations: ACEI, angiotensin converting enzyme inhibitor; ACS, acute coronary syndrome; ARB, 
angiotensin II receptor blocker; GRACE, Global Registry of Acute Coronary Events; NSTEMI, non-ST-
segment elevation myocardial infarction; STEMI, ST-segment elevation myocardial infarction, TIA, transient 
ischemic attack; UA, unstable angina  
 
Missing data: cognitive status (n=41), depressive symptoms (n=44) employment status(n=20), finances at the 
end of month (n=36), GRACE risk score (n=39), health literacy (n=9), living situation (n=2), race/ethnicity 
(n=2) 
 
*GRACE risk scores (2.0) incorporate data on age, cardiac biomarkers, ST segment changes, systolic blood pressure, 
creatinine or history of renal dysfunction, Killip class or use of diuretics, development of cardiac arrest during the index 
hospitalization to calculate risk for mortality at 1 and 3 years after admission for an ACS. It is scored on a scale from 0 to 
263, with higher scores indicating a higher probability of death. 
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Table 2.2: Crude all-cause mortality at 2-years after discharge for a 
hospitalization for an acute coronary syndrome and barriers to healthcare  
 
 
 
Overall  
Financial Barrier to 
Care  
No Usual Source 
of Care  
Transportation 
Barrier 
  (n=2,008)  Yes (n=665) 
No 
(n=1,343)  
Yes 
(n = 343) 
No 
(n = 1,665)  
Yes 
(n=239) 
No 
(n=1,769) 
Mortality 
(%)  5.0  4.4 5.3  6.4 4.7  8.4 4.5 
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Figure 2.1: Barriers to healthcare and all-cause mortality at 2-years after 
discharge for a hospitalization for an acute coronary syndrome 
 
 
 
 
 
Adjusted for site, sex, race/ethnicity, GRACE risk score (incorporates data on age, cardiac biomarkers, ST segment 
changes, systolic blood pressure, creatinine or history of renal dysfunction, Killip class or use of diuretics, development of 
cardiac arrest during the index hospitalization), education, living situation, ACS treatment, prior heart disease, prior 
peripheral vascular disease, prior history of chronic kidney diseases, depressive symptoms 
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Clinically	
Meaningful	
Increase
SF-36v2	PCS	Subscales Barrier (%)	 Initial	Y Final	Y Adjusted	OR LCI UCI DLC DUC
Unadjusted Financial	Barrier	to	Care Yes 36.4 75.2 65.2 0.69 0.40 1.19 0.29 0.50
No 31.5 68.9 58.9
No	Usual	Source	of	Care Yes 38.0 62.6 52.6 1.39 1.15 1.68 0.24 0.29
No 32.1 56.3 46.3
Transportation	Barrier Yes 43.0 49.9 39.9 2.08 1.57 2.74 0.51 0.66
No 31.0 43.6 33.6
37.3 27.3
Adjusted Financial	Barrier	to	Care Yes 30.9 31.0 21.0 0.81 0.49 1.33 0.32 0.52
No 25.0 24.7 14.7
No	Usual	Source	of	Care Yes 29.3 18.4 8.4 1.58 1.24 2.01 0.34 0.43
No 26.3 12.1 2.1
Transportation	Barrier Yes 33.3 5.8 -4.2 1.55 1.15 2.09 0.40 0.54
No 26.1
0.0
SF-36v2	MCS	Subscales
Vitality
Social	Functioning
Role-Emotional
Mental	Health
0.00 1.00 2.00 3.00
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Figure 2.2: A) Proportional Venn diagram depicting extent of overlap 
between barriers to healthcare access. B) Prevalence of different 
combinations of barriers to healthcare access and all-cause mortality at 2-
years after discharge 
	
 
 
1A)                            
 
 
 
 
 
1B) 
Barrier 
  
Financial No Usual Source of Care Transportation 
Total 
(n=2,008, col %) 
2-year mortality 
 (row %) 
No No No 54.3 5.3 
Yes No No 19.7 3.8 
No Yes No 8.0 4.4 
No No Yes 3.8 11.7 
Yes No Yes 5.1 3.9 
Yes Yes No 6.1 8.1 
No Yes Yes 0.8 12.5 
Yes Yes Yes 2.2 11.4 
 
 
 
 
  
Financial Barrier
No Usual Source of Care
Transportation
Barrier
Overall Sample (n=2,008)
396
77
160
44
16
123
102
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Figure 2.3: Number of barriers to healthcare access and all-cause mortality 
at 2-years after discharge for a hospitalization for an acute coronary 
syndrome 
 
 
 
Adjusted for site, sex, race/ethnicity, GRACE risk score (incorporates data on age, cardiac biomarkers, ST segment 
changes, systolic blood pressure, creatinine or history of renal dysfunction, Killip class or use of diuretics, development of 
cardiac arrest during the index hospitalization), education, living situation, ACS treatment, prior heart disease, prior 
peripheral vascular disease, prior history of chronic kidney diseases, depressive symptoms 
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Table 1.2: Crude all-cause mortality at 2-years after discharge for a hospitalization for an acute 
coronary syndrome and barriers to healthcare  
 
 
 
Overall  
Financial Barrier to 
Care  
No Usual Source 
of Care  Transportation Barrier 
  (n=2,008)  Yes (n=665) 
No 
(n=1,343)  
Yes 
(n = 343) 
No 
(n = 1,665)  
Yes 
(n=239) 
No 
(n=1,769) 
Mortality (%)  5.0  4.4 5.3  6.4 4.7  8.4 4.5 
 
 
 
 
 
 
 
 
 
 
 
 
 
Model  Barrier 
Hazard Ratio 
 (95% CI) 
   
Unadjusted 
Financial Barrier 0.69 (0.40, 1.19) 
No Usual Source of Care 1.39 (1.15, 1.68) 
Transportation Barrier 2.08 (1.57, 2.74) 
   
Adjusted 
Financial Barrier 0.81 (0.49, 1.33) 
No Usual Source of Care 1.58 (1.24, 2.01) 
Transportation Barrier 1.55 (1.15, 2.09) 
 
Adjusted for site, sex, race/ethnicity, GRACE risk score (incorporates data on age, cardiac biomarkers, ST segment 
changes, systolic blood pressure, creatinine or history of renal dysfunction, Killip class or use of diuretics, develop of 
cardiac arrest during the index hospitalization), education, living situation, ACS treatment, prior heart disease, prior 
peripheral vascular disease, depressive symptoms 
 
Figure 1.1: Barriers to healthcare and all-cause mortality at 2-years after discharge for a 
hospitalization for an acute coronary syndrome  
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Model  Barrier 
Hazard Ratio 
 (95% CI) 
   
Unadjusted 
No Barrier Present Referent 
1 Barrier Present 0.90 (0.53, 1.54) 
2 or More Barriers Present 1.41 (0.76, 2.60) 
   
Adjusted 
No Barrier Present Referent 
1 Barrier Present 0.99 (0.48, 2.02) 
2 or More Barriers Present 1.53 (1.03, 2.27) 
 
 
Figure 1.4: Number of barriers to healthcare and all-cause mortality at 2-years after discharge for 
a hospitalization for a  acute coronary syndr me 
 
Adjusted for site, sex, race/ethnicity, GRACE risk score (incorporates data on age, cardiac biomarkers, ST segment 
changes, systolic blood pressure, creatinine or history of renal dysfunction, Killip class or use of diuretics, develop of 
cardiac arrest during the index hospitalization, education, living situation, ACS treatment, prior heart disease, prior 
peripheral vascular disease, depressive symptoms 
 
Clinically	
Meaningful	
Increase
SF-36v2	PCS	Subscales Barrier (%)	 Initial	Y Final	Y Adjusted	OR LCI UCI DLC DUC
Unadjusted Financial	Barrier	to	Care Yes 36.4 75.2 65.2 0.00 0.00
No 31.5 68.9 58.9
1 Yes 38.0 62.6 52.6 0.90 0.53 1.54 0.37 0.64
No 32.1 56.3 46.3
2	or	More Yes 43.0 49.9 39.9 1.41 0.76 2.60 0.65 1.19
No 31.0 43.6 33.6
37.3 27.3
Adjusted Yes 30.9 31.0 21.0 0.00 0.00
No 25.0 24.7 14.7
1 Yes 29.3 18.4 8.4 0.99 0.48 2.02 0.51 1.03
No 26.3 12.1 2.1
2	or	More Yes 33.3 5.8 -4.2 1.53 1.03 2.27 0.50 0.74
No 26.1
0.0
SF-36v2	MCS	Subscales
Vitality
Social	Functioning
Role-Emotional
Mental	Health
0.00 1.00 2.00 3.00
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A.         B. 
Barrier 
  
Financial Usual Source of Care Transportation 
Total 
N (col %) 
2-year 
mortality 
n (row %) 
No No No 1,090 (54.3) 5.8 (5.3) 
Yes No No 396 (1.97) 15 (3.8) 
No Yes No 1 0 (8.0) 7 (4.4) 
No No Yes 77 (3.8) 9 (11.7) 
Yes No Yes 102 (5.1) 4 (3.9) 
Yes Yes No 123 (6.1) 10 (8.1) 
No Yes Yes 16 (0.8) 2 (12.5) 
Yes Yes Yes 44 (2.2) 5 (11.4) 
 
 
 
Figure 1.3: A. Proportional Venn diagram depicting extent of overlap between barriers to 
healthc re. B. Prevalence of different combinations of barriers to healthcare and all-cause 
mortality at 2-years after discharge Add numbers to Venn diagram 
 
 
 
 
 
Model  Barrier 
Hazard Ratio 
 (95% CI) 
   
Unadjusted 
No Barrier Present Referent 
1 Barrier Present 0.90 (0.53, 1.54) 
2 or More Barriers Present 1.41 (0.76, 2.60) 
   
Adjusted 
No Barrier Present Referent 
1 Barrier Present 0.99 (0.48, 2.02) 
2 or More Barriers Present .53 ( .03, 2.27) 
 
Adjusted for site, sex, race/ethnicity, GRACE risk score (incorporates data on age, cardiac biomarkers, ST segment 
changes, systolic blood pressure, creatinine or history of renal dysfunction, Killip class or use of diuretics, develop of 
cardiac arrest during the index hospitalization, education, living situation, ACS treatment, prior heart disease, prior 
peripheral vascular disease, depressive symptoms 
 
Figure 1.3: Numb of barri rs to healthcare acc ss and all-cause mortality at 2-years after 
discharge for a hospitalization for an acute coronary syndrome  
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CHAPTER III: BARRIERS TO HEALTHCARE ACCESS AND DECLINES IN 
HEALTH-RELATED QUALITY OF LIFE AMONG HOSPITAL SURVIVORS OF 
AN ACUTE CORONARY SYNDROME 
 
 
 
ABSTRACT 
Background: Little is known about how poor healthcare access may affect 
health-related quality of life (HRQOL) after an acute coronary syndrome (ACS).  
Methods: In a cohort of hospital survivors of an ACS at six medical centers in 
Massachusetts and Georgia in 2011-2013, we categorized patients as having a 
financial barrier, no usual source of care, or a transportation barrier to healthcare. 
Using the SF36v2 physical and mental component summary scores, we 
examined clinically meaningful declines in generic physical and mental HRQOL 
scores between 1 and 6 months post-discharge. Using Poisson regression 
models, we calculated relative risks (RRs) for declines in HRQOL according to 
the presence of the individual and total number of healthcare barriers while 
adjusting for several sociodemographic, clinical, and psychosocial factors.  
Results: Among the 1,053 survivors of an ACS, 29.0% had a financial barrier, 
14.2% had no usual source of care, and 8.7% had a transportation barrier. 
Patients with a financial barrier had greater risks of experiencing clinically 
meaningful declines in generic physical (adjusted RR 1.38, 95% CI: 1.10,1.72) 
and mental (adjusted RR 1.37, 95% CI 1.08, 1.74) HRQOL than those without a 
financial barrier. Compared to those with no barriers to care, those with two or 
more barriers had a higher risk of experiencing declines in generic physical 
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(adjusted RR 1.38, 95% CI: 1.09 to 1.75) and mental (adjusted RR 1.51, 95% CI: 
1.18, 1.93) HRQOL. 
Conclusions: Financial and multiple barriers to healthcare access may predict 
subsequent declines in generic HRQOL after a hospiutalization for an ACS. 
 
 
INTRODUCTION 
The majority of the 1.4 million American adults who annually survive a 
hospitalization for an acute coronary syndrome (ACS) avoid short-term 
readmission and death.2,5 However, they tend to have worse health-related 
quality of life (HRQOL) than the general population,77,78 and many experience 
subsequent declines in HRQOL after hospital discharge.79 The American Heart 
Association recommends that clinicians monitor HRQOL, particularly since poor 
HRQOL is associated with adverse clinical events and can change clinical 
management.80 Better knowledge about potential changes in HRQOL may be 
particularly useful for patients who are determining their long-term health 
goals,especially after being discharged from the hospital after an acute coronary 
event.80 
We know little about the factors that affect HRQOL after an ACS,80 
particularly with regards to healthcare access.81 Barriers to healthcare, including 
inadequate financial resources, lack of a usual source of care, and poor 
transportation access remain common in the U.S.23,76 Such barriers may lead to 
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poor uptake and adherence to secondary prevention therapies for coronary heart 
disease that could otherwise improve HRQOL.82,83 Limited data suggest that 
patients with specific healthcare barriers may consistently have lower HRQOL 
over periods up to one year after a hospitalization for an ACS.20,29 These studies 
did not, however, assess the relationship between barriers to healthcare and 
subsequent changes in HRQOL. Better understanding of the relationship 
between barriers to healthcare and subsequent changes in HRQOL may help 
identifty and treat patients at risk of health declines following an ACS.84,85  
Using data from the Transitions, Risks, and Actions in Coronary Events 
Center for Outcomes Research and Education (TRACE-CORE) study of hospital 
survivors of an ACS,55,56 we examined the association between financial barriers 
to healthcare, having no usual source of care, and transportation barriers to 
healthcare with clinically meaningful changes in HRQOL during the six months 
after hospital discharge.  
METHODS 
Source Study and Sample 
In the prospective TRACE-CORE cohort study,55,56 trained research 
assistants (RAs) recruited 2,174 adults who survived a hospitalization for ACS at 
6 medical centers in central Massachusetts and Georgia between April 2011 and 
May 2013. Eligibility criteria included being 21 years of age or older, having a 
confirmed ACS,65,66 and being discharged alive. Those with an ACS secondary to 
another acute medical event, delirium, pregnancy, or receiving hospice or 
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palliative care were ineligible. After being informed of the risks and benefits of 
participation, patients provided written consent. Trained RAs abstracted data 
from electronic medical records and conducted an interview, either in-person 
during the index hospitalization or by telephone, within 72 hours of discharge. 
Patients participated in additional telephone interviews at 1, 3, 6, and 12 months 
after discharge. This study received approval from the institutional review boards 
at participating sites.  
Participants with complete data on the specific barriers to healthcare, type 
of ACS, SF-36v2® Health Survey physical (PCS) and mental (MCS) component 
summary scores86 and Seattle Angina Questionnaire Quality of Life (SAQ QOL)87 
at 1 and 6 months after discharge, and various potentially confounding factors, 
comprised the analytical sample.  
Barriers to Healthcare 
As exposures, we examined variables in the TRACE-CORE study that 
could act as enabling resources in the Andersen Model of Access.63,64 These are 
factors that serve as logistical facilitators for accessing healthcare, namely 
having adequate financial resources, a usual source of care, and transportation 
for obtaining medical care.  
Financial Barriers to Care 
We defined financial barriers to healthcare as either difficulty affording 
care and/or a lack of insurance coverage at hospital discharge. Participants 
answered the following yes/no questions: “during the past 12 months, have you 
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had any problems paying medical bills?” and “in the past twelve months, have 
you avoided obtaining any health care services because of the cost?”20 We 
categorized patients responding affirmatively to either of these questions and/or 
lacking insurance as having a financial barrier to healthcare.  
Lacking a Usual Source of Care 
During the baseline interview, participants answered the question “is there 
a place that you usually go to when you are sick or need advice about your 
health?” Those responding yes received an additional prompt to classify this 
place as a clinic or health center, doctor’s office or HMO, emergency room, or 
outpatient department.23 Using the methodology of the National Health Interview 
Survey,23 we classified patients responding no to the first question or listing an 
emergency room in the second question as having no usual source of care. 
Transportation Barriers to Care 
To assess the presence of transportation-related barriers to medical care, 
participants answered the following questions during the baseline interview: 
“overall, and in terms of transportation, how difficult is it for you to get to your 
health care appointments?” (no problem at all, not very, somewhat, moderately, 
or extremely difficult) and “within the past 12 months, have you missed a medical 
appointment or been unable to obtain needed health care because of problems 
with your transportation?” (yes, no). We classified patients who reported missing 
care or perceiving moderate to extreme difficulty in getting to appointments as 
having a transportation barrier.  
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Multiple Barriers to Healthcare 
We examined the relationship between changes in HRQOL with the 
number of barriers to healthcare access. We lacked sufficient numbers to assess 
the relationships between each potential combination of barriers to healthcare 
access with changes in HRQOL. We instead categorized patients as having no 
barriers, 1 barrier, or 2 or more barriers to healthcare.  
Changes in Health-Related Quality of Life  
To assess generic HRQOL at 1 and 6 months after hospital discharge, 
participants completed the SF-36v2 Health Survey.86 The SF-36v2 contains PCS 
and MCS scores that assess overall physical and mental health with higher 
scores indicating better HRQOL. The scales use norm-based scoring such that 
the U.S. general population has a mean of 50 (SD 10).86. Following 
recommendations from the instrument developer, we defined changes of ≥ 3.0 
points as clinically meaningful decreases and increases in HRQOL.88 Prior 
results support the reliability and validity of the SF-36v2® among patients with 
coronary heart disease.89  
To assess disease-specific HRQOL, we used the 3-item quality of life 
subscale of the Seattle Angina Questionnaire (SAQ QOL),87 an instrument 
developed for, as well as validated with, patients with coronary heart disease.87 
The SAQ QOL is scored from 0 to 100; higher scores indicate better HRQOL. 
Following expert consensus,90 we defined changes of ≥ 16.0 points as clinically 
meaningful decreases and increases in HRQOL. Since both the SF-36v2 and 
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SAQ inquire about health status in the month prior to survey administration, we 
used the 1-month rather than baseline assessments of HRQOL. 
Additional Variables  
The RAs abstracted data on patient’s age and sex from hospital medical 
records. Patients self-described their race and ethnicity, education level, 
household composition, employment status, and smoking status during the 
baseline interview. Cardiologists classified patients’ type of ACS as either an ST-
segment elevation myocardial infarction (STEMI), non-STEMI, or unstable angina 
according to abstracted ECG, cardiac biomarker, and cardiac catheterization 
data.65,66 The RAs also abstracted data on patients’ pre-existing medical 
conditions and hospital treatment practices. We calculated Global Registry of 
Acute Coronary Events (GRACE) risk scores (2.0) using data on age, cardiac 
biomarkers, ST segment changes, systolic blood pressure, creatinine or history 
of renal dysfunction, Killip class or use of diuretics, and development of cardiac 
arrest during the index hospitalization.67 GRACE 2.0 scores are scaled from 0 to 
263, with higher scores indicating a higher probability of death.67 
During the index hospitalization, RAs asked participants “how confident 
are you filling out medical forms by yourself?” on a 5-point Likert scale (not at all, 
a little bit, somewhat, quite a bit, or extremely confident);68 we categorized those 
responding extremely/quite a bit, somewhat, and a little bit/not at all as having 
high, medium, and low health literacy, respectively. We assessed cognitive 
status using the Telephone Interview for Cognitive Status (TICS) at 1 month after 
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hospital discharge.69 Using cut-points from the instrument developer, we 
classified participants as having normal cognitive functioning, ambiguous 
functioning, or mild to severe cognitive impairment. At 1 month, patients 
completed the 6-item Patient Activation Measure, a measure of patients’ 
knowledge, skills and confidence to manage their disease.79,91 We assigned 
participants to 1 out of 4 possible levels of activation according to pre-specified 
cut-points from the instrument developer.79,91  
Statistical Analysis 
We examined the baseline sociodemographic, clinical, and psychosocial 
characteristics of participants according to the presence of a financial, usual 
source of care, and transportation-related barrier with the receipt of healthcare. 
We used chi-square goodness of fit tests and unpaired t-tests to compare 
differences in the distributions of categorical and continuous variables, 
respectively, among those with and without selected specific healthcare barriers. 
We examined differences in mean HRQOL scores between 1 month and 6 
months after discharge using paired t-tests.   
Using Poisson regression models with a sandwich error term,92 we 
calculated relative risks (RR) and accompanying 95% confidence intervals (95% 
CIs) for experiencing a clinically meaningful decrease in HRQOL at 6 months 
according to the presence of individual healthcare barriers. We used this 
approach as the high prevalence of the outcome would violate the rare disease 
assumption in calculating odds ratios.92 We first constructed a model that 
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contained the three healthcare barriers together. We then adjusted the models 
for pre-specified sociodemographic (age, sex, race) and clinical factors (GRACE 
risk score and reperfusion therapy) as well as selected covariates if their 
inclusion changed beta coefficients (for the association between at least one 
barrier to access and changes in HRQOL) by ≥10%. Since preliminary analyses 
showed a strong association between initial HRQOL and subsequent changes in 
HRQOL scores, suggesting potential regression to the mean, we also adjusted 
for 1-month HRQOL scores.  
To examine potential selection bias resulting from differential loss to 
follow-up, we also performed regression analyses using inverse probability 
weighting.93 The weighted results were comparable to unweighted results 
(Appendix 3.1 and 3.2). Thus, we present unweighted results only. 
  
RESULTS 
Baseline Population Characteristics  
The analytical sample consisted of 1,053 of the 2,174 original TRACE-
CORE study participants. Compared to included participants, those excluded 
were younger and more likely to belong to a racial or ethnic minority, have less 
education, be unemployed, and have strained monthly finances (p<0.001 for all 
comparisons). Excluded participants were also more likely to have previously 
diagnosed heart failure, be a current smoker, not have undergone a 
percutaneous coronary intervention during their acute hospitalization, have an 
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index length of hospital stay greater than 3 days, have worse health literacy, and 
have impaired cognition than included participants (p<0.05 for all comparisons). 
The prevalence of financial barriers to care (38.4% vs. 29.0%), lack of a usual 
source of care (19.3% vs 14.2%), and transportation barriers (14.4% vs. 8.7%) to 
care were significantly higher among excluded than included participants 
(p<0.001 for all comparisons).  
In the analytical sample, 305 (29.0%) participants had a financial barrier, 
149 (14.2%) lacked a usual source of care, and 92 (8.7%) had a transportation 
barrier to receiving healthcare. Participants with each barrier tended to be 
younger, female, of a racial or ethnic minority, unemployed, not living with a 
spouse, and have strained monthly finances than those without the specific 
barrier (Table 3.1, p<0.05 for all comparisons). The prevalences of chronic lung 
disease, current smoking status, and mildly to severely impaired cognitive status 
were higher among those with the specific barriers to healthcare access 
compared to those without (p<0.05 for all comparisons). 
Physical HRQOL 
Mean PCS scores increased by 1.6 points (p<0.001) between 1 and 6 
months after hospital discharge, from 42.4 to 44.0 points, although 25.5% of 
participants experienced a clinically meaningful decrease in their generic physical 
HRQOL (i.e., ≥ 3 points). Patients with each specific healthcare barrier had 
significantly lower mean PCS scores at 1 and 6 months post-discharge 
compared to their counterparts without such barriers (Table 3.2, p<0.001 for all 
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comparisons). Overall, 31.5% who reported a financial barrier to care, 22.0% 
who lacked a usual source of care, and 31.5% who had a transportation barrier 
to care experienced a clinically meaningful decline in their physical HRQOL. 
Patients with a financial barrier to care had a significantly higher risk of 
experiencing a clinically meaningful decrease in their physical HRQOL compared 
to those without a financial barrier (adjusted RR 1.38, 95% CI: 1.10 to 1.72), but 
not those lacking a usual source of care or having a transportation barrier (Table 
2).  
Mental HRQOL 
Mean MCS scores of the sample increased by 1.7 points from 50.9 points 
at 1 month to 52.6 points at 6 months post-discharge (p<0.001), but 25% of 
patients experienced a clinically meaningful decline in MCS scores (i.e., ≥ 3 
points). Mean MCS scores were significantly lower among participants with each 
kind of healthcare barrier compared to those without such barriers at 1 and 6 
months post hospital discharge (Table 3.3, p<0.001 for all comparisons). Slightly 
less than one third of participants with a financial barrier, lack of a usual source 
of care, or transportation barrier experienced a clinical meaningful decline in their 
mental HRQOL. Patients with a financial barrier to healthcare had significantly 
higher risk (adjusted RR 1.37, 95% CI 1.08 to 1.74) of a meaningful decline in 
their mental HRQOL compared to those without a financial barrier to care 
between 1 and 6 months post-discharge.  
Disease-Specific HRQOL 
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The mean disease-specific HRQOL scores of the sample increased by 4.7 
points from 76.2 to 80.9 points between 1 and 6 months post-discharge 
(p<0.001). Overall, 12.7% of participants experienced a clinically meaningful 
decline in their disease specific HRQOL (i.e., ≥ 16 points) during the 6 months 
after hospital discharge (Table 3.4). Participants with each healthcare barrier had 
lower mean SAQ QOL scores than their counterparts without such a barrier at 1 
and 6 months post hospital discharge (Table 3.3, p<0.001 for all comparisons). 
Participants with each form of healthcare barrier had a modest, non-significantly 
elevated risk of experiencing declines in disease-specific HRQOL over the six 
months after hospital discharge.  
Number of Barriers to Healthcare 
Overall, 54.5% of patients had no healthcare barriers, 12.4% had just one 
barrier, and 33.1% had two or more barriers. Table 3.5 shows that the 
prevalence of clinically meaningful declines in PCS and MCS scores increased 
with increasing number of barriers to healthcare (p trend < 0.01), but not for SAQ 
QOL scores. Patients with two or more healthcare barriers had a higher risk of 
experiencing declines in generic physical (adjusted RR 1.38, 95% CI: 1.09 to 
1.75) and mental (adjusted RR 1.51, 95% CI: 1.18 to 1.93) HRQOL over six 
months compared to those without any healthcare barriers. After multivariable 
adjustment, the magnitude of the point estimates for the relative risks of 
experiencing clinically meaningful declines in PCS and MCS scores increased 
with the number of patient barriers to healthcare access (p for trend <0.01 for 
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both comparisons). We did not identify higher risks of declines in disease-specific 
HRQOL in those with one, as well as two or more, healthcare barriers compared 
to those without any healthcare barriers.  
DISCUSSION 
This prospective observational study of more than 1,000 hospital survivors 
of an ACS found that about one quarter of participants experienced a clinically 
meaningful decline in their physical and mental HRQOL over the six months after 
hospital discharge, while about one-tenth experienced a decline in disease-
specific HRQOL. Compared to patients without barriers to healthcare, patients 
with a financial barrier had higher risks of experiencing clinically meaningful 
declines in physical and mental HRQOL over this period, but not those lacking a 
usual source of care or having a transportation barrier. We found that those with 
two or more specific barriers to care also had higher risks of experiencing 
declines in physical and mental HRQOL compared to those with no barriers. To 
the best of our knowledge, these are the first results to identify an association 
between barriers to healthcare with subsequent declines in generic mental and 
physical HRQOL after an ACS. We did not identify any association with the 
individual and total number of barriers to healthcare access with increased risks 
of experiencing declines in disease-specific HRQOL. 
 Barriers to Healthcare Access and HRQOL Scores 
A limited number of studies have examined the relationship between 
healthcare access and HRQOL at a pre-specified time following hospitalization 
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for an ACS, but did not examine changes over time.20,29 In a nationwide cohort 
study of 2,498 patients who survived their hospitalization for an acute myocardial 
infarction (AMI) between 2003-2004, those reporting avoiding healthcare due to 
costs reported lower mean generic physical and mental HRQOL, as well as SAQ 
HRQOL, at one year after discharge compared to those without such a barrier.20 
Similarly, a risk standardization model developed with a cohort of 4,340 survivors 
of AMI recruited from 24 nationwide hospitals between 2005-2008 also found an 
association with cost-related avoidance of healthcare with lower SAQ HRQOL 
scores at one year post-discharge.29 We could not identify any prior studies that 
examined the relationship between lacking a usual source of care nor having a 
transportation barrier with HRQOL after an ACS. Our findings show that those 
with a financial barrier to care, who lacked a usual source of care, or with a 
transportation barrier tended to have lower generic and disease-specific HRQOL 
than their counterparts at 1 and 6 months following hospital discharge. Clinicians 
seeking to optimize the well-being of their patients may want to pay particular 
focus to those with barriers to care.  
Changes in Physical HRQOL 
Our results suggest that those with financial barriers to care may also be 
more likely to experience subsequent declines in physical HRQOL. Patients with 
difficulty affording healthcare may be less likely to receive follow-up care and 
effective therapies, such as cardiac rehabilitation, that would otherwise protect 
their physical health.9 Alternatively, such patients may unnecessarily limit 
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physical activities after their ACS because they lack reassurance about their 
safety from healthcare providers. Qualitative and survey studies suggest that 
survivors of an ACS restrict physical work, even when objective tests 
demonstrate excellent exercise capacity, due to fears of inciting a subsequent 
coronary event.94,95 Given that exercise may have a protective effect against a 
recurent coronary event, financial barriers to healthcare could further adversely 
affect patient’s long-term survival.96  
Changes in Mental HRQOL 
As with changes in generic physical HRQOL, participants reporting a 
financial barrier to healthcare were more likely to experience a subsequent 
decline in generic mental HRQOL compared to those without such a barrier. In 
general, survivors of an ACS have a high risk of developing depression,97 the 
severity of which can be captured in the mental health subscale, and is 
correlated with overall MCS scores.86 Patients with financial constraints on their 
healthcare may have difficulty accessing standard therapies for depression, 
including pharmacotherapy and cognitive-behavioral therapy, and/or be less 
adherent to these treatment modalities than patients without cost-related 
constraints.97 Moreover, the constrained-financial resources themselves, rather 
than the lack of professional psychological services, could cause declines in 
mental HRQOL. Since secondary prevention treatment may impose substantial 
out-of-pocket costs on patients,98,99 patients may have to make financial 
sacrifices, such as foregoing social activities, that would otherwise sustain their 
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spirits, or skip treatment and worry about an increased risk of a recurrent 
coronary event.15  
We were surprised to not find an association between lacking a usual 
source of care or having a transportation barrier with experiencing clinically 
meaningful declines in either physical or mental HRQOL. Conceivably, the same 
factors that cause a patient to have a financial barrier to healthcare could also 
lead someone to lack a usual source of care and have a transportation barrier. 
Our adjusting for financial barriers could mask an association between the other 
two factors with declines in HRQOL. Alternatively, historical data suggests that 
many patients lack a usual source of care due to having good health and/or 
perceiving no need to regularly see a doctor.100,101 Our inability to find an 
association between lacking a usual source of care with declines in HRQOL 
could result from us not being able to distinguish patients who could not obtain 
such care from those who did not require a usual source of care. Alternatively, 
some patients with a transportation barrier at admission may have been able to 
receive transport help from social contacts or through arrangements by 
healthcare providers after discharge, thereby attenuating the association 
between transportation barriers with subsequent declines in HRQOL. Future 
studies should specify the exact reason for patients lacking a usual source of 
care and transportation for healthcare visits.  
Changes in Disease-Specific HRQOL 
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In our data, individual and composite measures of barriers to healthcare 
did not predict declines in disease-specific HRQOL over the six months after 
hospital discharge with statistical significance. However, the positive point 
estimates for these relationships may suggest that this study was under 
powered. Alternatively, the three relevant items on the SAQ QOL measure ask 
patients to assess the impact of angina-like symptoms on their enjoyment of life, 
their satisfaction with their current state of anginal symptoms, and their overall 
concern about a subsequent coronary event.87 Discrepancies between the 
generic physical and disease-specific HRQOL measures may be due to the 
latter’s emphasis on symptoms of angina. 
While the results of this study are insufficient to recommend particular 
interventions to optimize HRQOL after an ACS, it does leave open the possibility 
that actions to improve healthcare access may result in better HRQOL. A 
contemporary systematic review on interventions and changes in HRQOL after 
an AMI did not identify any studies that used improvements in healthcare 
access.83 Some evidence suggests that improvements in HRQOL may result 
from improving healthcare access among the general population. An analysis of 
20,745 individuals in the Portland, Oregon metropolitan area randomized to 
receive, or not, an invitation to apply for Medicaid in 2008 found that those 
offered to receive health coverage had greater generic mental HRQOL, on 
average, after two years compared with those who did not receive an offer to 
apply.102 Similarly, the coverage gains through the 2006 Massachusetts 
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healthcare reform and 2010 Affordable Care Act may have also led to gains in 
beneficiaries self-reported health.84 As results from healthcare policy initiatives 
suggest that improvements in healthcare access may enhance HRQOL,84 further 
research is warranted to more fully understand how enhancing healthcare access 
among survivors of an ACS may also improve their HRQOL and how providers 
might play a critical role in this process.  
Study Strengths and Limitations  
Strengths of this study include its large sample size and assessment of 
multiple barriers to healthcare as well as generic and disease-specific forms of 
HRQOL. In assessing clinically meaningful changes in HRQOL, we not only 
measured an outcome that matters to patients, but also permitted better 
identification of patients at risk of poorer outcomes than by examining mean 
changes in HRQOL. We acknowledge several limitations including the potential 
for selection bias due to fairly high loss to follow-up. Our study sample may not 
be representative of the national population of ACS survivors. Since this study 
did not assess changes in healthcare access over time, patients who 
experienced changes in their access following hospital discharge may have been 
misclassified. We also did not have insurance claims for participants describing 
their use of medications and clinician services in the time after hospital discharge 
that would better elucidate the potential mechanisms between barriers to 
healthcare and declines in HRQOL. Lastly, unmeasured confounders, such as 
the receipt of social services during and after hospitalization, changes in 
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employment, or family related matters may have affected the relationship 
between barriers to healthcare access and changes in HRQOL.  
Conclusion 
In this study, survivors of an ACS who have difficulty affording healthcare 
are more likely to experience clinically meaningful declines in generic HRQOL 
than patients with better healthcare access. Given the high prevalence of barriers 
to healthcare in the U.S., additional research is warranted to finding the best 
approaches to improve healthcare access among patients with an ACS, and 
perhaps, consequentially, their health status through actions such as health 
policy changes and better referral of at-risk patients to support services.  
.   
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Table 3.1: Baseline characteristics of survivors of a hospitalization for an 
acute coronary syndrome according to presence of specific barriers to 
healthcare access  
 
Characteristics  
Full Sample 
(n = 1,053)  
Financial 
Barrier 
(n = 305)  
No Usual 
Source of 
Care 
(n = 149)  
Transportation 
Barrier 
(n = 92) 
Sociodemographic          
Age, mean, yrs (SD)  62.7 (10.8)  58.2 (9.9)  57.5 (11.1)  59.6 (10.0) 
Female (%)  33.0  41.3  27.5  44.6 
Non-Hispanic White (%)  80.3  68.9  63.8  63.0 
Education (%)         
  Less than high school  10.6  16.1  18.1  22.8 
  High school  29.5  35.7  40.9  29.3 
  Some college / post-high school   30.8  30.2  25.5  30.4 
  College graduate  29.1  18.0  15.4  17.4 
Living Situation (%)         
   With spouse  52.4  42.6  35.6  26.1 
   With family (non-spouse)  14.2  21.0  22.1  28.3 
   With non-family  13.3  14.1  18.8  19.6 
   Alone  20.0  22.3  23.5  26.1 
Employment Status (%)         
   Retired  42.5  26.9  20.8  32.6 
   Working  40.9  40.7  50.3  21.7 
   Unemployed  16.6  32.5  28.9  45.7 
Finances at End of Month (%)         
   Some left over  50.7  21.0  38.3  18.5 
   Just enough to make ends meet  34.1  43.0  34.9  41.3 
   Not enough to make ends meet  15.2  36.1  26.8  40.2 
Clinical          
GRACE score, mean (SD)*  96.1 (26.5)  90.0 (25.4)  89.9 (25.8)  96.6 (27.0) 
Prior Medical History (%)         
   Arthritis  21.2  19.0  14.1  20.7 
   Cancer  12.2  11.5  11.4  13.0 
   Chronic lung disease  18.0  22.6  20.8  30.4 
   Chronic kidney disease  9.5  8.9  12.1  20.7 
   Diabetes  30.9  38.0  25.5  54.3 
   Heart disease  50.3  56.7  48.3  68.5 
   Heart failure  11.2  14.1  8.7  22.8 
   Hyperlipidemia  70.7  73.1  59.1  77.2 
   Hypertension  75.0  77.4  68.5  87.0 
   Peripheral vascular disease  9.6  9.2  9.4  17.4 
   Stroke/TIA  8.4  8.9  7.4  14.1 
Smoking Status (%)         
   Never smoked  31.1  26.9  20.8  18.5 
   Former smoker  49.1  42.3  43.0  45.7 
   Current smoker  19.8  30.8  36.2  35.9 
ACS Type (%)         
   STEMI  16.0  11.5  16.1  10.9 
   NSTEMI  54.9  58.4  55.7  57.6 
   UA  29.2  30.2  28.2  31.5 
Reperfusion Therapy (%)         
   PCI  69.2  68.9  61.1  69.6 
   CABG Surgery  12.9  10.5  16.8  13.0 
   No PCI nor CABG  17.9  20.7  22.1  17.4 
Length of stay ≥ 3 Days (%)  49.4  50.5  55.0  57.6 
 
 
(continued) 
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Table 3.1 (continued). 
 
Characteristics 
 
Full Sample 
(n = 1,053)  
Financial 
Barrier 
(n = 305)  
No Usual 
Source of 
Care 
(n = 149)  
Transportation 
Barrier 
(n = 92) 
Psychosocial          
Health Literacy (%)         
   High  69.0  61.6  65.1  50.0 
   Medium  16.4  17.4  14.1  30.4 
   Low  14.5  21.0  20.8  19.6 
Cognitive Status (%)         
   Normal  67.1  59.3  54.4  43.5 
   Ambiguous   29.5  34.8  40.3  46.7 
   Mildly or Severely Impaired  3.3  5.9  5.4  9.8 
Patient Activation (%)         
   Level 1: Disengaged (lowest)  8.8  12.8  10.1  17.4 
   Level 2: Aware  40.7  40.7  41.6  43.5 
   Level 3: Taking Action  21.2  21.0  20.8  15.2 
   Level 4: Maintaining Behaviors   29.2  25.6  27.5  23.9 
 
Abbreviations: ACS, acute coronary syndrome; NSTEMI, non-ST-segment elevation myocardial infarction; 
STEMI, ST-segment elevation myocardial infarction, TIA, transient ischemic attack; UA, unstable angina  
 
*GRACE risk scores (2.0) incorporate data on age, cardiac biomarkers, ST segment changes, systolic blood pressure, 
creatinine or history of renal dysfunction, Killip class or use of diuretics, development of cardiac arrest during the index 
hospitalization to calculate risk for mortality in-hospital, with higher scores indicating a higher probability of death. 
 
  
 	
Table 3.2: Scores and clinically meaningful declines in generic physical health-related quality of life among 
survivors of an acute coronary syndrome between and 1 and 6 months after hospital discharge  
 
 Financial Barrier to Care No Usual Source of Care Transportation Barrier 
 Yes 
(n = 305) 
No 
(n = 748) 
Yes 
(n = 149) 
No 
(n = 904) 
Yes 
(n = 92) 
No 
(n = 961) 
Mean SF36v2 PCS Scores       
1 Month Post Discharge (SD) 39.2 (10.8) 43.7 (9.9) 41.1 (10.5) 42.6 (10.3) 38.7 (10.0) 42.7 (10.3) 
6 Month Post Discharge (SD) 40.0 (11.9) 45.7 (10.9) 42.9 (11.8) 44.2 (11.5) 38.6 (11.5) 44.5 (11.4) 
Mean Change (SD) 0.8 (8.7) 2.0 (8.5) 1.8 (8.4) 1.6 (8.6) -0.1 (8.0) 1.8 (8.6) 
Experiencing Clinically Meaningful 
Decline (%) 31.5 23.0 22.2 26.0 31.5 24.9 
Relative Risks Ratios (95% CI) for 
Clinically Meaningful Decline 
      
Adjusted for Barriers Only 1.36 (1.10, 1.70) Referent 0.81 (0.59, 1.11) Referent 1.17 (0.83, 1.63) Referent 
Fully Adjusted* 1.38 (1.10, 1.72) Referent 0.87 (0.63, 1.22) Referent 1.00 (0.72, 1.39) Referent 
 
Note: The SF36v2 PCS is scored on a scale of 0-100 with higher scores indicating better generic physical health-related quality of life. A clinically meaningful decrease was 
defined as a decline of ≥3.0 points between 1 and 6 months after hospital discharge.  
 
*Adjusted for clinical site, age, sex, race/ethnicity, education, employment status, reperfusion therapy, GRACE risk score (incorporates data on age, cardiac biomarkers, ST 
segment changes, systolic blood pressure, creatinine or history of renal dysfunction, Killip class or use of diuretics, development of cardiac arrest during the index 
hospitalization), 1 month SF36v2 PCS score, 1 month SF36v2 MCS score  
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Table 3.3: Scores and clinically meaningful declines in generic mental health-related quality of life among 
survivors of an acute coronary syndrome between and 1 and 6 months  
 
 
 Financial Barrier to Care No Usual Source of Care Transportation Barrier 
 Yes 
(n = 305) 
No 
(n = 748) 
Yes 
(n = 149) 
No 
(n = 904) 
Yes 
(n = 92) 
No 
(n = 961) 
Mean SF36v2 MCS Scores       
1 Month Post Discharge (SD) 47.4 (12.5) 52.3 (10.2) 47.6 (13.8) 51.4 (10.2) 44.3 (13.0) 51.5 (10.3) 
6 Month Post Discharge (SD) 48.8 (12.4) 54.1 (9.8) 49.4 (14.0) 53.1 (10.5) 44.4 (13.4) 53.3 (10.8) 
Mean Change (SD) 1.4 (10.6) 1.8 (9.2) 1.9 (11.2) 1.7 (9.4) 0.1 (10.8) 1.9 (9.5) 
Experiencing Clinically Meaningful 
Decline (%) 30.8 22.1 28.2 24.0 32.6 23.8 
Relative Risks Ratios (95% CI) for 
Clinically Meaningful Decline 
      
Adjusted for Barriers Only 1.35 (1.07, 1.69) Referent 1.11 (0.84, 1.47) Referent 1.23 (0.88, 1.71) Referent 
Fully Adjusted* 1.37 (1.08, 1.74) Referent 1.12 (0.84, 1.49) Referent 1.28 (0.91, 1.80) Referent 
 
Note: The SF36v2 MCS is scored on a scale of 0-100 with higher scores indicating better generic mental health-related quality of life. A clinically meaningful decrease was 
defined as a decline of ≥3.0 points between 1 and 6 months after hospital discharge.  
 
*Adjusted for age, sex, race, clinical site, employment status, reperfusion therapy, 1 month SF36v2 MCS score 
 
 
 
 
 
 
 
 
 
 
 
  
56 
C
hapter III 
 	
 
Table 3.4: Scores and clinically meaningful declines in disease-specific health-related quality of life among 
survivors of an acute coronary syndrome between and 1 and 6 months after hospital discharge  
 
 
 Financial Barrier to Care No Usual Source of Care Transportation Barrier 
 Yes 
(n = 305) 
No 
(n = 748) 
Yes 
(n = 149) 
No 
(n = 904) 
Yes 
(n = 92) 
No 
(n = 961) 
Mean SAQ QOL Scores       
1 Month Post Discharge (SD) 68.0 (25.2) 79.5 (20.5) 69.3 (24.7) 77.3 (22.0) 64.5 (25.2) 77.3 (22.0) 
6 Month Post Discharge (SD) 73.9 (24.0) 83.7 (18.4) 73.0 (27.2) 82.2 (19.1) 68.3 (27.4) 82.1 (19.5) 
Mean Change (SD) 5.8 (20.9) 4.2 (19.3) 3.7 (21.3) 4.9 (19.5) 3.8 (24.4) 4.8 (19.3) 
Experiencing Clinically Meaningful 
Decline (%) 14.1 12.2 17.5 12.0 16.3 12.4 
Relative Risks Ratios (95% CI) for 
Clinically Meaningful Decline 
      
Adjusted for Barriers Only 1.09 (0.77, 1.55) Referent 1.42 (0.96, 2.11) Referent 1.22 (0.75, 2.03) Referent 
Fully Adjusted* 1.07 (0.75, 1.55) Referent 1.22 (0.81, 1.82) Referent 1.08 (0.66, 1.77) Referent 
 
 
Note: The Seattle Angina Questionnaire quality of life (SAQ QOL) questionnaire is scored on a scale of 0-100 with higher scores indicating better disease-specific health-
related quality of life. A clinically meaningful decrease was defined as a decline of ≥16.0 points between 1 and 6 months after hospital discharge.  
 
*Adjusted for age, sex, race, clinical site, education, living situation, reperfusion therapy, GRACE risk score (incorporates data on age, cardiac biomarkers, ST segment 
changes, systolic blood pressure, creatinine or history of renal dysfunction, Killip class or use of diuretics, development of cardiac arrest during the index hospitalization), 1-
month SAQ QOL score, 1 month SF36v2 MCS score 
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Table 3.5: Clinically meaningful declines in health-related quality of life 
among survivors of an acute coronary syndrome between and 1 and 6 
months after hospital discharge according of total number of barriers to 
healthcare access 
 
 
 No Barriers (n = 630) 
1 Barrier 
(n = 118) 
2 or More 
Barriers 
(n = 305) 
SF36v2 PCS Scores    
Experiencing Clinically Meaningful Decrease (%) 22.9 23.7 31.5 
Relative Risks Ratios (95% CI) for  
Clinically Meaningful Decrease    
Unadjusted Referent 1.04 (0.73, 1.48) 1.38 (1.11, 1.71) 
Adjusted* Referent 1.01 (0.70, 1.47) 1.38 (1.09, 1.75) 
    
SF36v2 MCS Scores    
Experiencing Clinically Meaningful Decrease (%) 21.1 27.1 30.8 
Relative Risks Ratios (95% CI) for 
 Clinically Meaningful Decrease    
Unadjusted Referent 1.28 (0.92, 1.76) 1.46 (1.17, 1.83) 
Adjusted† Referent 1.35 (0.97, 1.88) 1.51 (1.18, 1.93) 
    
SAQ QOL Scores    
Experiencing Clinically Meaningful Decrease (%) 11.4 16.1 14.1 
Relative Risks Ratios (95% CI) for 
Clinically Meaningful Decrease    
Unadjusted Referent 1.41 (0.88, 2.25) 1.23 (0.87, 1.75) 
Adjusted‡ Referent 1.06 (0.67, 1.70) 1.09 (0.74, 1.61) 
 
 
Note: For the SF36v2 PCS and MCS, a clinically meaningful decrease was defined as a decline of ≥3.0 points between 1 
and 6 months after hospital discharge. For the Seattle Angina Questionnaire quality of life (SAQ QOL) scale, a clinically 
meaningful decrease was defined as a decline of ≥16.0 points between 1 and 6 months after hospital discharge. 
 
* Adjusted for clinical site, age, sex, race/ethnicity, education, employment status, reperfusion therapy, GRACE risk score, 
1 month SF36v2 PCS score, 1 month SF36v2 MCS score  
† Adjusted for age, sex, race, clinical site, employment status, reperfusion therapy, 1 month SF36v2 MCS score 
‡ Adjusted for age, sex, race, clinical site, education, living situation, reperfusion therapy, GRACE risk score, 1-month SAQ 
QOL score, 1 month SF36v2 MCS score 
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CHAPTER IV: HOMEWARD BOUND: PATIENTS’ PERSPECTIVES  
ON CARE TRANSITIONS AFTER A HOSPITALIZATION 
 
 
ABSTRACT 
Background: Poor care transitions from the hospital to home (transitions) may 
lead to adverse patient outcomes. As reimbursement becomes increasingly 
linked to clinical and patient-centered outcomes, providers have strong incentives 
to better manage transitions. Patients may possess key insights to better assess 
and improve transitions.  
Methods: In this qualitative study, we performed semi-structured concept 
elicitation interviews with patients experiencing a transition following an 
unplanned hospitalization in medical and surgical wards at a single academic 
medical center. Three analysts independently analyzed transcripts to identify 
themes within and outside the medical centers that influenced patients’ transition. 
Results: Our analyses of interview transcripts of 22 patients identified four 
themes related to actions of discharging medical centers and five themes outside 
of the direct purview of the discharging hospital that influence transitions. In the 
medical center, participants generally described positive roles for quality patient-
centered care, opportunities for patient participation, comprehensive discharge 
education, and coordination of medical services on their transitions. Outside of 
the medical center, participants reported that having caregiver support, social 
support, health literacy, adequate health insurance, and accessibility to 
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healthcare and non-healthcare resources following hospital discharge assisted 
their transitions. 
Conclusions: This qualitative study suggests that both actions of medical 
centers to engage and assist patients and a patient’s ability to utilize resources 
contributes to successful transitions. Future work on strategies to develop better 
patient-centered transitions, and their effect on patient outcomes is warranted.  
 
INTRODUCTION 
Care transitions home after an unplanned hospitalization require complex 
coordination among patients, caregivers, and multiple providers over a short 
period of time, and therefore presents multiple opportunities for harmful and 
costly errors.42-44 One quarter of preventable 30-day readmissions may result 
from failures in the transition process such as inadequate patient education, 
outpatient follow-up, and medication reconciliation.103 Trials have shown that 
interventions on care transition process, such as providing patient education, 
case management, and early follow up, can improve patient outcomes.104,105 
However, there is a lack consensus on optimal transition practices.105,106  
Better understanding of patient perspectives may better inform 
interventions for transitions.107 As patients may be the only common link between 
different providers in the fragmented US healthcare system,108 their input may be 
essential for designing optimal transitional care. In this qualitative study, we 
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sought to identify and describe patient views on key factors for transitions to the 
home after an unplanned hospitalization.  
 
METHODS 
This study uses data from an ongoing, PCORI-funded project to develop a 
new validated measure of patient perceptions of the quality of transitions. To 
identify pertinent domains, we interviewed 22 patients who were discharged 
directly home after an unplanned hospitalization for an acute surgical or medical 
condition at a 781-bed tertiary care hospital in central Massachusetts.  
Materials  
Drawing upon themes identified in the literature and prior studies of 
transitions, we developed a preliminary guide for semi-structured concept 
elicitation interviews for patients to identify and describe factors relevant to their 
transition from hospital to home. An iterative process of consultation from two 
clinicians with experience in transitional care, input from a multi-stakeholder 
advisory board of 2 clinicians, 1 nurse, 3 patients, and 1 healthcare administrator, 
and results of patient piloting testing, informed the development of the final guide. 
Starting with open-ended questions followed by specific, verbal probes, the guide 
directed patients to describe their overall transitions and factors influencing their 
transitions within and outside of the healthcare system.  
Recruitment and Interviews 
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Eligible participants were 21 years or older, fluent in English, had an 
unplanned admission lasting two or more midnights (inpatient), and were 
discharged alive. Exclusion criteria included having a planned admission, a prior 
hospitalization within 90 days, observational status (less than two midnights), 
and/or cognitive impairment. Using purposive sampling,109 providers identified 
potential participants treated in surgical and medical wards; study staff 
approached inpatients, and described the study along with potential benefits and 
risks. Participants who provided written consent participated in an audio-recorded 
in-person or telephone interview with one of two trained interviewers between 23 
to 73 days after hospital discharge (median:33).  
Study staff approached 75 out of 110 potentially eligible participants; 37 
enrolled in the study. Between October 2015 and March 2016, study staff 
conducted 14 in-person interviews and 8 telephone interviews; interviewers were 
unable to schedule times to interview the other 15 enrollees. Interviews lasted 13 
to 44 minutes (mean 23.2). Interview audio recordings were transcribed and 
imported into NVivo v.11.3.2 for coding and analysis (QSR International, 
Melbourne, Australia). The University of Massachusetts Medical School 
Institutional Review Board approved this study. 
Analysis 
Using triangulation,110 transcripts were analyzed by three investigators 
from diverse academic backgrounds to minimize disciplinary and personal bias. 
Following grounded theory, an inductive approach,111,112 each analyst reviewed 
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transcripts to identify concepts, categories, and themes. Through a process of 
open coding, each team member independently generated nodes for newly 
identified themes.113 To achieve consistency between coders, the team used a 
constant comparison method whereby they would meet to compare coding and 
memo descriptions of the interviews. Inter-coder agreement was evaluated, 
allowing a unified codebook, or taxonomy, to emerge.114 The analysts reviewed 
the coding taxonomy, with any disagreements resolved by an independent 
adjudicator. We stopped after the 22nd interview as we had reached theoretical 
saturation.115  
RESULTS  
Among the 22 participants, ages ranged from 22 to 82 (median = 56.5), all 
but 4 were non-Hispanic and white, 13 were male;  18/22 had admissions to 
medical, rather than surgical, services (Table 4.1). We identified 23 separate 
concepts that were pertinent to the scope of this manuscript that we summarized 
into nine themes (Table 4.2) that are described with representative quotations in 
Tables 4.3 and 4.4.  
Themes Related to the Discharging Medical Center  
Care Quality: All participants reported that the perceived quality of their 
inpatient care influenced the success of their transition, particularly with regards 
to the length of hospital stay, information exchange, and provider-rapport. 
Participants reported the importance of being kept in the hospital for sufficient but 
not excessive periods of time. Some participants felt frustrated when break 
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downs in coordination after successful treatment of their medical issue made 
their hospital stays unnecessarily lengthy. Others felt that they were discharged 
too soon after they received treatment for their health issues; they would have 
preferred longer stays in order to be more emotionally ready for discharge and 
have more monitoring by health professionals before returning home.  When 
providers kept “the patient informed” about his or her in-hospital treatment and 
discharge planning, participants felt greater satisfaction, had more opportunities 
to “mentally prepare” for their transitions, and were better able to make 
arrangements with non-professional caregivers to ease the transition home. 
Optimal steps for communication included informing which provider(s) were 
primarily responsible for their care, ensuring providers took “their time to explain 
everything” and answer questions, and accommodating language barriers by 
speaking slowly, using interpretative services, and providing documentation in 
the patient’s native language. Seven participants described how confidence in 
their transition was enhanced through better rapport with providers, such as 
having providers demonstrate “concern” about their care and on “trying to get 
[patients] out of the hospital” as soon as possible.  
Patient Participation: Participants described how being “involved in the 
discharge planning” was beneficial for their transitions (Table 2). Perceived 
benefits of patient participation included ensuring patients were physically and 
emotionally “ready to go home,” had special services set up before discharge, 
were able to follow the proposed discharge plan, and had adequate time to plan 
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for their transition before discharge as well as to question providers about their 
post-hospital care.  
Discharge Education: All participants reported receiving education about 
their transition, with varying levels of satisfaction. Participants learned about their 
diagnosis and hospital course, disease management, limitations to performing 
activities of daily living, symptoms requiring urgent evaluation, contacts for 
questions, follow up care, discharge medications, and potential adverse 
medication effects. Some participants reported receiving inadequate information 
about “how big a risk” they had for disease complications and about who to 
contact for medical advice after discharge. All participants reported receiving 
verbal and written discharge instructions, with one participant describing written 
instructions as a “confidence booster” during the transition. All participants 
reviewed their discharge instructions with a nurse; a few desired an opportunity 
to ask additional questions with a physician following this. Several participants 
reported difficulty comprehending verbal instructions due to perceived medication 
side effects and being “groggy” after a long hospital stay. 
Coordination: All participants described either directly or potentially 
benefiting from inpatient providers coordinating services and outpatient care 
during transitions. Participant responses suggested a preference for having 
inpatient providers minimize the patients’ burden to organize healthcare after 
discharge. For instance, participants favorably described inpatient providers 
scheduling outpatient follow-up, obtaining transportation services, scheduling in-
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home services before discharge, and contacting outpatient pharmacies. 
Participants found in-home services, such as visiting nurses, to be valuable 
resources. Overall, participants benefited from outpatient follow-up care, 
describing these providers as “tighten[ing] up loose ends” and serving as “checks 
and balances to make sure everything is going well.” Participants saw poor 
coordination including lack of follow-up after discharge, outpatient care 
scheduled long after discharge, and improperly timing in-home services as 
failures in their transitions.  
Themes Outside of the Discharging Medical Center  
Caregiver Support: Overall, participants reported receiving assistance 
from a caregiver during their transition including a spouse or partner, child, 
sibling and/or parent (Table 3). Participants positively described caregiver 
involvement in the hospital to review and finalize the care plan and “asking 
questions,” particularly if patients were experiencing cognitive impairment. After 
discharge, participants reported a variety of help from caregivers in tasks such as 
interpreting and implementing the care plan, delivering “psychological support,” 
providing “help with medications,” driving for appointments and errands, and 
preparing meals. Five participants described how their caregiver helped carry out 
activities of daily living that they could not otherwise accomplish due to their 
medical condition.  
Social Support: Interviewers queried participants on how social support 
beyond their caregivers might impact the care transition; participants described a 
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positive role for social support including extended family, friends, and members 
of religious organizations (Table 3). Social support was noted to ease the stress 
of the transition. Participants reported that social networks were helpful for 
obtaining meals, transportation, and fulfilling errands. One participant noted that 
“community is a big thing in making sure you can get back to normal.”  
Health Literacy: All 22 participants discussed benefits of written 
(“understand the paperwork”) and oral health literacy (“the ability to ask 
questions”) in their care transitions, mainly as a product of their formal education. 
Five participants described greater education as being an asset during in-hospital 
discharge education, particularly for comprehension and having productive 
conversations with providers. After hospital discharge, participants who at least 
had some college described having greater education as being beneficial for 
implementing the care plan, problem solving, and obtaining resources to better 
understand their disease. The five participants who received a high school 
diploma or less all denied that their education background affected their 
transition, although one also noted that “it’s a lot easier if you have a little bit 
more education to help understand what you should do.” Three participants with 
prior healthcare training described their educational background as an important 
asset in the transition.  
Health Insurance: Twenty participants reported that health insurance had 
an important role both during and after their hospitalizations. Three participants 
reported concern that inadequate coverage may lead to premature discharge. In 
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contrast, one patient described her insurer “blocking” her discharge because of 
its refusal to cover a medication. Eight participants reported that inadequate 
health insurance could prevent patients from executing the post-discharge 
treatment through financial barriers to obtaining medications, outpatient follow-up 
care, and in-home services. Four participants noted how sufficient health 
insurance coverage led to less stress during their transition. Two participants 
denied that their insurance coverage affected their transition; one patient 
reported that she “always had this insurance,” while another reported that “it 
shouldn’t [matter] unless you don’t have it.”  
Accessibility: Participants described the importance of accessibility to 
healthcare and other resources for the transition as determined by their 
residential location and access to transportation. Participants noted that 
transportation was needed to obtain prescription medications, attend outpatient 
follow-ups, and acquire essentials such as groceries. Nine participants reported 
that a caregiver or friend supported their transition by “play[ing] chauffeur” when 
they could not drive. Participants described low socioeconomic status, lack of 
social support, and medication side effects as specific barriers to transportation. 
Nine participants (including 3 suburban, 2 rural, 2 urban residents) indicated that 
a “larger population [area] is better for more immediate support” stating that 
transitions may be more difficult in rural areas with little or no public 
transportation and further distance from social support pharmacies, hospitals, 
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and stores. However, participants viewed home location only to be a problem if a 
patient lacked a source of transportation. 
DISCUSSION 
Our interviews with 22 patients with unplanned hospitalizations reveal that 
patients perceive factors within and beyond the direct control of the discharging 
hospital influenced their transitions. In general, patients viewed provider actions 
to deliver patient-centered care, invite patient participation, provide discharge 
education, and to coordinate services to be particularly beneficial for their 
transitions. Patients also found their transition to be facilitated by caregiver 
assistance, social support, greater education, adequate health-insurance, and 
accessibility to health resources.  
Participants’ experience suggests that medical centers can improve 
transitions by involving patients’ in the discharge process while limiting their need 
to coordinate their own care following discharge. Better patient participation, 
comprehensive discharge education, and care coordination appear to be 
plausible strategies in addressing deficits found in quantitative studies of 
transitions. Poor patient education and follow-up care were identified as leading 
causes of preventable readmissions among 1,000 patients treated between 
2012-2013 at 12 nationwide academic medical centers.116 However, multiple 
barriers exist for improving transitions through the mechanisms reported by our 
study participants. Suboptimal patient participation in healthcare may result from 
low health-literacy, cognitive impairment, and inadequate provider time or 
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inclination.117 Inadequate discharge education may result from the lack of 
standardized processes to assess patients’ informational needs.118 Failures of 
coordination between inpatient and outpatient providers also result from the 
fragmentation of care, lack of financial resources, and inadequate training.119 
Lastly, absent financial compensation or incentives, healthcare systems may lack 
the resources to adopt transition interventions that patients value..105,120,121   
Medical centers may encounter additional challenges in overcoming 
deficits in factors beyond their direct control. Many caregivers lack the training 
and emotional resilience for such roles; policymakers and clinicians have 
historically neglected to include and support caregivers.122 Better transitions may 
results from engaging caregivers in the discharge process and through enhanced 
coordination of post-discharge services. The presence of additional social 
support besides the primary caregivers may reduce stress, promote better self-
care behaviors, and be protective against hospital readmissions.123,124 Providers 
have tested physical and virtual support groups to furnish additional social 
support to patients with chronic diseases, but the scalability of such interventions 
remain questionable.123 
Participants also benefited from additional internal and external resources 
apart from those provided by the discharging medical center, including health-
literacy, health insurance, and accessibility to healthcare resources. Participants 
described the utility of written and oral health literacy during and after hospital 
discharge. Systematic review and meta-analytic evidence suggests that patients 
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with worse literacy may have worse treatment adherence and clinical 
outcomes.125,126 This emphasizes the importance of assessing and 
accommodating patients’ literacy levels,127 particularly when a high proportion of 
discharge education materials may be unsuitable for some individuals.128 A 
similar awareness about patients’ ability to access healthcare resources based 
on their home location and availability of transportation may also benefit 
transitions; although government and commercial payers offer non-emergency 
medical transportation, many such services can be costly, and historically have 
been unreliable.47 The influence of these factors in patient transitions suggests 
the difficulty of finding a “one-size” fits all approach towards transitions.  
Our findings both overlap and extend upon themes identified as being 
influences on pertinent transitions in other qualitative studies. In conducting 
formative interviews for the development of the Care Transition with 49 elderly 
patients with a recent transition, Coleman and colleagues perceived adequate 
information transfer, patient and caregiver preparation, self-management 
support, and empowerment to assert preferences as elements of good 
transitions.129 An ethnographic study of 24 enrollees of Kaiser Permanente also 
identified inclusion of caregivers, personal connection with providers, ability to 
implement health knowledge into self-care, and making advanced arrangements 
to fulfill needs as some of the key elements of transitions from the hospital to the 
outpatient setting.130 A qualitative study of 40 patients who experienced 
transitions home with home health services, along with 35 caregivers and 15 
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home health clinicians, also described the importance of adequately educating 
patients and caregivers prior to discharge as well providing comprehensive 
discharge instructions for transitions.131 Such themes overlap with our findings on 
the importance of quality of patient-centered care, discharge education, 
coordination, and caregiver support on transitions. Our results also provide 
additional emphasis on the need to consider patients’ healthcare resources, 
accessibility, and health literacy in planning transitions.  
We acknowledge several limitations. As with all qualitative research, we 
present exploratory findings that do not provide conclusive evidence of the 
influence of the described factors on care transitions. While our sample includes 
participants with diverse medical conditions, age, and education-levels the 
generalizability of our findings may be limited from our sampling English 
speakers at a single academic medical center in the northeastern US. We 
performed semi-structured interviews with prompts for many of the themes 
presented in our findings; this may have biased the participants towards 
considering certain items as influencing their care transitions. 
CONCLUSIONS 
This qualitative analysis of patients’ experience transitioning home after an 
unplanned hospitalization suggests that both patients’ individual circumstances 
and clinician actions influence the success of care transitions. Additional study of 
the role patient factors in care transitions, and ways in which hospital systems 
can address deficits in these factors, is warranted.  
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Table 4.1: Sociodemographic and clinical characteristics of qualitative 
interview participants (n=22) with an unplanned hospitalization  
 
Characteristic   
Age, (y), median (Range) 56.5 (22 to 82) 
  < 50  5/22 
  50 – 59  7/22 
  60 – 69  6/22 
  70 or older 4/22 
Female (n) 9/22 
Non-Hispanic White (n) 18/22 
Education*   
 High School or Less 5/17 
 Some College 5/17 
 2-4 Years of College 4/17 
 Graduate Education 3/17 
Primary Diagnosis (n)  
Cardiovascular  
  Acute Coronary Syndrome 4 
  Angina, Stable 1 
  Dysrhythmia  2 
  Heart Failure 2 
  Pericarditis  1 
Pulmonary  
  Asthma Exacerbation 3 
  Pulmonary Embolism 1 
  Pulmonary Hypertension 1 
Surgical  
  Acute Limb Ischemia 1 
  Small Bowel Obstruction 1 
  Trauma 2 
Other  
  Migraine  1 
  Sepsis 2 
 
*education data unavailable for 5 participants 
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Table 4.2: Concepts identified in qualitative interviews with patients (n=22) 
on care transitions, organized into 9 themes   
 
Themes  
 
Concepts  
Related to the Discharging Medical Center  
Quality of Inpatient, Patient-Centered Care Reason for Hospitalization 
Appropriate length of stay 
Communication with provider 
Languages spoken 
Patient Participation  Patient involvement in discharge process 
Discharge Education  Information given at discharge  
Understanding medication 
Receiving discharge information 
Additional discharge information requested 
Coordination Healthcare professional at home 
Helpfulness of discharger 
Logistics of discharge  
Outpatient clinical care post-discharge  
Post-discharge services 
Outside of the Discharging Medical Center  
Caregiver Support  Caregiver involvement in discharge process 
Caregiver-provider communication 
Social Support  Role of external social support 
Health Literacy  Literacy impact 
Education impact 
Health Insurance  Financial resources  
Insurance impact on transition  
Accessibility  Geographical impact on transition 
Transportation and transition 
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Table 4.3: Themes and key quotations exemplifying patient perspectives on 
themes related to the discharging medical center as important for the care 
transition home after an unplanned hospitalization  
 
Themes Outside the 
Discharging Medical Center 
Important to Care Transitions 
(number of participants citing 
this theme) 
Representative Quotations 
Quality of Inpatient, Patient-
Centered Care (22/22) 
“I think that keeping the patient informed as soon as the medical 
people have the info is the best time to do it. If that’s the first day, then 
they can outline it. Or if not, they can say we’re not sure about your 
discharge, we need to run these tests. If it’s the next day and they say 
you’ll be going home in a couple of nights, that’s fine too.” 
 
“[My doctor] and I hit it off and he’s looked out for me and I respect him 
a lot for all of the things he did. He tells me I compliment him too much 
but he saved my life but he’s just an incredibly warm man, very 
concerned about, in this case the heart and all of the functions that 
surround it.   
 
Patient Participation (20/22) “It’s always good to be involved in this. It’s good to have a lot of input 
on what the transition to home is going to be. It’s good to be helpful 
and to tell the hospital what situations I am going to be in; like how my 
house is set up and whether I have to climb stairs so they know how to 
help me.”  
 
“I liked that they asked me if I felt ready to go home. And liked that they 
told that if I didn’t feel ready I didn’t have to be rushed out. And I was 
like ‘no I’m ready’, you know.”  
 
Discharge Education (22/22) “I think if you have any questions, they should answer them, which they 
did. I think they should give you some idea of how long it should take 
you to reach the point that you want to reach. And what to expect and 
what not to expect. In my case, my walking is not going to get any 
better.”  
 
“I was given a list of medication and prescriptions and instructions on 
how to take them. I was given a list of things I should do, can’t do, 
limitation, numbers to call in case I had any questions. I was told that if 
such and such happens to this degree you don’t have to treat it as an 
emergency then call us the next day. If this happens to an extended 
degree, then call us right away. If it happens to you in a much larger 
degree then call 9-1-1….It was given to me by the nurse, the day of my 
discharge both verbally and on paper. She sat down on a chair next to 
me and asked me questions. … She was even able [to answer] simple 
questions like, if want coffee, should I have caffeinated or 
decaffeinated.”  
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Table 4.3 (continued) 
 
Coordination (22/22) “They just made sure I had everything. They actually faxed over my 
prescriptions to, you know, the CVS for me. The nurse actually went 
above and beyond and you know, walked the list down the pharmacy 
here so they would be ready when I was leaving with my family 
member and they just didn’t accept my health insurance. So she came 
all the way back upstairs to give them to me instead of just leaving 
them down there. And then went above and beyond and asked to the 
nurse to fax them to my CVS. So that was very helpful, very helpful.”  
 
“The [Visiting Nurse Association] was sending nurses and I was on the 
Coumadin… But I am glad that they were available and were able to 
come see me.... The nurses did ask me those questions every time 
they came… they asked me a question if I had blood in my stool and I 
think so but the color of the stool was black and like tar and that’s what 
told them that I should go to the emergency and sure enough I was 
bleeding.”  
 
“Once I am discharged I am on my own. However, I never got any 
follow-up. That was very surprising to me. Because usually we go to 
urgent care and get some prescriptions and the next day they call to 
see how you are doing. We didn’t get any call for two weeks. There is 
some tension in there.”  
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Table 4.4: Themes and key quotations exemplifying patient perspectives on 
patient-centered factors related to the care transition home after an 
unplanned hospitalization  
 
Themes Outside of the Discharging 
Medical Center Identified as Important 
to Care Transitions 
(number of participants citing this theme) 
Representative Quotations 
Caregiver Support (16/22) “He was the advocate, he was the one asking questions 
and making sure that everything was lined up. I couldn’t 
move a whole bunch, so he was helping me get to the 
car, helping me get out of the car, um packing up all me 
stuff, making sure all of the follow up appointments were 
kind of ready and set up.”  
 
“I was not in my right mind. I read my discharge papers 
over and over and over, looking for, you know…I just 
couldn’t keep focus. So the fact that I had a family 
member there, who was like ‘no, this is why you were 
there, this is the medication…’ You know, just…I can’t 
imagine being alone in that process.”  
 
“My wife was there; she helped to drive me home, she 
provided food, she provided help when I couldn’t get up, 
she made sure I was taking my medications at the right 
time because I was in pain and couldn’t do too much. 
She did everything I needed.”  
 
Social Support (21/22) “You may have anxiety about leaving the hospital and 
[social support] can help with those kinds of feelings. 
When I first came home the hospital I was afraid to leave 
the house because I felt like I would have another heart 
attack and there would be no one there to help.”  
 
“Social support is very important because it kind of helps 
you forget what you are going through. I have a lot of 
support from church and my friends… I have people 
visiting me every day bringing me things like fruit and 
items. And I have people praying for me.”  
Health Literacy (22/22) “A lot of the stuff that was talked about was knowledge I 
knew from pharmacy and being a dentist. I certainly felt 
like I could discuss with them on a different playing field 
then a lot of people would be able to discuss as far the 
medications and the symptoms and the cause and 
effects. It was advantage to have some knowledge to 
know how things work. You sometimes have more 
knowledge than the doctors do.” 
 
“I don’t think I received any education [on asthma]. 
Again, because I do research and I’m a professor, I know 
how to get in to the NIH website and download all the 
studies and I can understand them when I read them, but 
how typical is that?” 
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Table 4.4 (continued) 
 
Health Insurance (20/22) “In my case I have good insurance. I don’t have to wait 
for bills to be paid and that’s a great privilege. If I had to 
pay thousands of dollars I would be very worried about it 
and I wouldn’t be able to focus on my recovery with all 
that worry.”   
 
“Some health insurance only covers so much and then 
you have to pay out of pocket for the rest. Which that 
could impact the way they do things. They could miss 
appointments. Anything that was important to their 
recovery, they may, um, you know not take it as 
seriously as they should.”  
Accessibility (22/22) “Access to transportation becomes a class issue. If can’t 
afford to buy to car then you don’t have access to this 
kind of transportation. If you don’t have money to take 
the bus or take a cab then this is an issue. This all has to 
do with your economic status in life. Your status on the 
economic ladder in life determines your type of 
transportation. If you don’t have a car, then how do you 
get to places?”  
 
“The first couple of weeks I wasn’t able to drive. So, if I 
didn’t have somebody here to be able to drive me. If you 
lived in an area that didn’t have access to public 
transportation, then that would impact your ability to have 
follow up care.”  
 
“I think [being in a] rural [area] would be a deficit 
because things are so much further away like hospitals, 
medicines, stores, support group, that sort of thing. I 
think that in circumstances a larger population is better 
for more immediate support.” 
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CHAPTER V: DISCUSSION AND CONCLUSIONS 
 
This dissertation examined how barriers to healthcare access affect all-
cause mortality and changes in health status following a hospitalization for an 
ACS. Using data from a contemporary cohort of over 2,000 hospital survivors of 
an ACS, the first study aim found that patients who either lacked a usual source 
of care or had a transportation barrier to healthcare experienced higher rates of 
two-year post-discharge all-cause mortality than those without such barriers. The 
second study aim examined clinically meaningful changes in generic and 
disease-specific HRQOL over six months post-discharge among approximately 
1,100 members of the same study cohort. We found that those with a financial 
barrier to healthcare were more likely to experience clinically meaningful declines 
in generic physical and mental HRQOL than those without such a barrier. The 
final study aim described the perspectives of 22 patients with a recent unplanned 
hospitalization on factors affecting their transition home both within, and outside 
of, the healthcare system.  In these interviews, patients described the importance 
of having adequate transportation and health insurance to receive follow-up care 
following discharge from the hospital, suggesting one potential mechanism by 
which poor access to healthcare could result in worse clinical outcomes following 
a hospitalization. The three study aims provide both qualitative and quantitative 
evidence that barriers to healthcare may lead to more difficult transitions from the 
hospital and adverse health consequences.  
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Financial Barriers to Care 
Recent policy actions and trends in the health insurance market suggest 
that, in the short term, the prevalence of financial barriers to healthcare may 
increase. In 2010, the federal government passed the Affordable Care Act (ACA), 
a broad law intended to expand health insurance coverage, improve health 
outcomes, and reduce the rate of growth in overall, national healthcare 
expenditures.1 Although a subsequent Supreme Court ruling and Congressional 
actions blocked full implementation of the ACA, by 2015 the proportion of 
Americans with health insurance coverage reached an all-time high, with much of 
this gain being directly attributed to provisions of the ACA.2,3 Many, however, 
have vigorously sought repeal of the ACA due to a variety of concerns over the 
manner of its passage, concerns about its constitutionality, federal overreach, 
and cost, in addition to political opportunism.4,5 In the summer of 2017 Congress 
almost passed legislation that would have effectively ended the ACA in its 
present form and reversed gains in health insurance coverage.6 The current 
presidential administration has issued executive orders and performed 
administrative actions that could limit opportunities for enrollment through federal 
exchanges, force individuals out of the market due to premium increases, and 
provide cheaper plans that would provide potentially inadequate coverage.7,8 
Moreover, insurances premiums continue to rise faster than inflation, and 
increasing numbers of Americans have insurance plans with high-cost, out-of-
pocket deductibles.9,10 In light of potential reductions in insurance coverage and 
Chapter V 
	
81 
81	
increasing financial burdens on healthcare consumers, providers should be 
aware of how financial barriers to healthcare may harm patient outcomes. 
While this thesis does not explore how to fix financial barriers to 
healthcare, our results suggest that such barriers are common among survivors 
of an ACS and that addressing them may help prevent declines in HRQOL 
following hospital discharge. In our first study (Aim 1) we found that about a third 
of patients in a large, diverse sample of survivors of an ACS had a financial 
barrier to healthcare. Such high prevalence should encourage clinicians to 
regularly screen their patients for financial difficulties and consider the costs of 
treatment options for patients. While patients may be reluctant to disclose 
financial difficulties without prompting from a clinician, conversations about costs 
may help identify lower-cost treatment alternatives that patients would find easier 
to follow.11,12  
Currently, patient HRQOL is rarely assessed.13 Our findings also suggest 
that clinicians may want to pay closer attention to the physical and mental health 
status of patients with financial barriers to care, even though little is known about 
how to maintain or improve HRQOL among patients with heart disease.13 Studies 
are needed to clarify the association between financial barriers to healthcare and 
declines in HRQOL following a hospitalization for an ACS, in particular to see if 
relieving financial barriers to healthcare can improve HRQOL. For instance, 
studies of the recent Medicaid expansion experiment in Oregon suggest that 
previously uninsured patients who were offered the opportunity to enroll in 
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Medicaid reported better overall HRQOL one year after randomization compared 
to those who did not receive an opportunity to enroll.14  This thesis suggests the 
importance of developing better awareness about patients’ financial barriers to 
healthcare and the potential impact of such a barrier on HRQOL.    
Usual Source of Care 
While there has been considerable recent national attention on financial 
barriers to healthcare in the US due to the debate over modifying the ACA, the 
country also faces a worsening shortage of primary care clinicians, the most 
common providers of a usual source of care.15 Moreover, many individuals with 
no obvious barriers may not establish a usual source of care because they feel 
no immediate need.16 To the best of our knowledge, only one other study has 
examined the consequences of lacking a usual source of care on all-cause 
mortality after surviving a hospitalization for an ACS.17 Both that study and our 
work suggest that those lacking a usual source of care may have higher rates of 
long-term all-cause mortality. Future research could elucidate potential 
mechanisms that may be responsible for these observed associations, such as 
greater difficulty establishing outpatient follow-up after hospital discharge.  Future 
studies should seek to better distinguish between patients who lacked a usual 
source of care due to personal preference from those who were simply unable to 
obtain one. If lack of a usual source of care does contribute to worse outcomes 
following a hospitalization for an ACS, policies and actions that increase the 
numbers of Americans with a usual source of care should help.   
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Transportation Barrier to Care 
To the best of our knowledge, this is the first study to demonstrate that 
survivors of an ACS reporting a transportation-related healthcare barrier may 
have a heightened risk for long-term all-cause mortality following hospital 
discharge. However, we did not find that those with transportation barriers were 
more likely to experience declines in generic and disease-specific HRQOL than 
their peers with good transportation access. One potential explanation for this 
dichotomy may be the substantial loss-to-follow up in the HRQOL study aim 
resulting in selection bias for patients with having poor transportation but 
avoiding declines in HRQOL. Alternatively, patients with transportation barriers 
tended to have the lowest HRQOL compared to their peers; they may have been 
less likely to experience declines in HRQOL by having lower HRQOL at the start. 
Regardless, we believe that our results send an important message to clinicians 
about both the potential consequences on mortality due to a lack of 
transportation, as well as the potential for those with a transportation barrier to 
have, on average, a worse health status. Given the potential for transportation to 
be made increasingly accessible through smartphone-connected ride-sharing 
platforms, future studies could examine how eliminating transportation barriers 
could improve patient outcomes. 
Healthcare Barriers and Patient Perspectives on Care Transitions 
If indeed the above described barriers to healthcare contribute to mortality 
and/or HRQOL-related declines following a hospitalization for an ACS, one 
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possibility is that they lead to worse transitions of care to the outpatient setting 
that ultimately lead to poorer overall outcomes. In examining the perceptions of 
medical and surgical patient who experienced a recent transition home after an 
unplanned hospitalization, we found that patients viewed a diverse array of 
factors within and outside of the healthcare as influencing the success of their 
transition. Notably, participants described how accessibility to healthcare 
services, particularly adequate transportation, was essential for obtaining follow-
up care, prescriptions, and social support.  Similarly having adequate insurance 
(that mitigated financial barriers to care) helped to ensure that patients would 
adhere to outpatient care as well as preventing the psychological distress of 
being unable to afford care. Thus, this third study suggests the mechanisms by 
which financial and transportation barriers to health care could influence clinical 
outcomes.  While the third study aim did not specifically ask about having a usual 
source of care prior to their hospitalizations, several participants noted the 
importance of coordination between inpatient and outpatient providers, which 
should be easier for those with a usual source of care.   
Future Directions 
We can suggest several potential directions for future studies building on 
our findings that patients with specific barriers to healthcare access are more 
likely to experience adverse health outcomes following a hospitalization for an 
ACS. By studying patients hospitalized at select medical centers in 
Massachusetts and Georgia, our results may lack generalizability. Given 
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substantial variations in healthcare access at both the state and community 
level,18 future work in this field should incorporate a greater number of medical 
centers in geographically diverse locations. Such studies could also distinguish 
outcomes due to individual patient barriers versus the characteristics of clinical 
systems treating disadvantaged patients. It would be useful to identify and study 
clinical systems that have patients with better health outcomes despite barriers to 
healthcare access, in order to identify ways in which such barriers can be 
overcome.  
In addition to incorporating a larger number of clinical sites, future studies 
would benefit from incorporating even more variables pertaining to healthcare 
access. As described in the introduction, healthcare access results from a 
complex interaction of healthcare and patient-centered factors, many of which we 
could not account for in the first two study aims.19 For instance, we were unable 
to assess factors related to the approachability of healthcare systems, such as 
the availability for local primary care providers and cardiologists to provide timely 
follow-up care for patients or their willingness to accept particular forms of health 
insurance, such as Medicaid. An example of a patient-centered factor to be 
accounted for in future studies could be perceived need for healthcare following 
hospital discharge; effect estimates in this study may have been biased towards 
the null if patients who had good healthcare did not receive outpatient care after 
hospital discharge due to personal perceptions.   
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We also did not identify the particular mechanisms through which barriers 
to healthcare access could bring about worse health outcomes. Future studies 
could collect data on the consumption of healthcare resources following a 
hospitalization for an ACS, such as outpatient visits and emergency room, and 
prescription drug use. By combining such data with analytical methods such as 
mediation analysis, it may be possible to more precisely understand the causal 
pathways by which barriers to healthcare access influence patient outcomes 
following a hospitalization for an ACS.   
 Assuming that a relationship is established between barriers to healthcare 
access and poor outcomes after an ACS, clinicians will likely want to know how 
to screen for barriers to healthcare access and what interventions might help. 
While this thesis used a specific set of questions to determine healthcare access, 
these may not be the best way to assess healthcare access. Our third study 
suggests the utility of tools to assess 1) the healthcare access characteristics of 
a healthcare system, and 2) the individual healthcare access characteristics of a 
patient. It may be that some patients have healthcare access deficits that could 
more easily be handled by some systems than others.  
CONCLUSIONS 
 Specific barriers to healthcare access may harm HRQOL-related 
outcomes and survival following a hospitalization for an ACS; patients also 
perceive adequate healthcare access as an important facilitator of care 
transitions home following discharge from the hospital. Future studies should 
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explore the mechanisms by which barriers to access affect health, particularly by 
accounting for the multiple, complex patient-centered and healthcare system-
oriented factors that constitute healthcare access. Such information could inform 
intervention studies to demonstrate the extent to which addressing healthcare 
barriers can improve patient outcomes. For the meantime, clinicians may be able 
to achieve better outcomes by screening for barriers to healthcare and 
accounting for them in their treatment plans. As policymakers debate the extent 
of the government’s role in healthcare financing and delivery, the public may 
particularly benefit from better understanding the adverse consequences of 
inadequate access to healthcare. 
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APPENDICES FOR CHAPTER II 
Appendix 2.1: Fully adjusted model for assessing the relationship between 
individual barriers to healthcare access and all-cause mortality at 2-years 
after discharge for a hospitalization for an acute coronary syndrome  
 
 
Variable Meaning Exp(b) (95% CI) 
    
1_probaffordcare Financial barrier to healthcare access .8067735 (0.4877355, 1.334501) 
0_probaffordcare No financial barrier to healthcare access Referent - 
    
1_nousoc Has no usual source of care 1.579893 (1.242683, 2.008606) 
0_nousoc Has usual source of care Referent - 
    
1_reachingcare Transportation barrier to healthcare 1.551654 (1.151812, 2.090299) 
0_reaching care No transportation barrier to healthcare Referent - 
    
0_grace_risk_simpl GRACE Risk Score <100 Referent - 
1_grace_risk_simpl GRACE Risk Score >= 100 to <130 3.788572 (3.233139, 4.439425) 
2_grace_risk_simpl GRACE Risk Score >= 130 to <150 10.99798 (7.525892, 16.07193) 
3_grace_risk_simpl GRACE Risk Score >= 150 17.29312 (11.24443, 26.59556) 
    
0_site_cat Academic hospital – Worcester, Mass. Referent - 
1_site_cat Community hospital - Worcester, Mass. 0.2575456 (0.2451202, 0.2706008) 
2_site_cat Academic hospital – Macon, Georgia 2.042115 (1.700956, 2.451699) 
3_site_cat Community hospital, Atlanta, Georgia 3.170515 (2.823493, 3.560188) 
    
1_female Female 0.8429521 (0.4797331, 1.481174) 
0_female Male Referent - 
    
1_race_whitehisp Non-Hispanic white  1.333025 (0.8331162, 2.132902) 
0_race_whitehisp Not non-Hispanic white Referent - 
    
0_acs_trt Received percutaneous intervention Referent - 
1_acs_trt Received coronary artery bypass graft 0.3324538 (0.1024079, 1.079267) 
1_acs_trt Received medications only 1.099872 (0.8025591, 1.507326) 
    
0_liv_sit Lives with spouse Referent - 
1_liv_sit Lives with family 1.240019 (0.7540508, 2.039181) 
2_liv_sit Lives with non-family 1.482076 (1.306833, 1.680819) 
3_liv_sit Lives alone 1.116261 (0.8732555, 1.426889) 
    
1_educ_simpl Less than high school Referent - 
2_educ_simpl High school graduate .8175456 (0.5321572, 1.255984) 
3_educ_simpl Post high school / some college .8163778 (0.5429369, 1.227532) 
4_educ_simpl College graduate .5401994 (0.2817703, 1.03565) 
    
1_chd Prior diagnosis of coronary heart disease 1.386727 (0.9685315, 1.985493) 
0_chd No prior diagnosis of coronary heart disease Referent - 
    
1_ckd Prior diagnosis of chronic kidney disease 1.39536 (1.18875, 1.63788) 
0_ckd No prior diagnosis of chronic kidney disease Referent - 
    
1_pvd Prior diagnosis of peripheral vascular disease 1.858307 (1.462165, 2.361774) 
1_pvd No prior diagnosis of peripheral vascular disease Referent - 
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Appendix 2.2: Fully adjusted model for assessing the relationship between 
individual barriers to healthcare access and all-cause mortality at 2-years 
after discharge for a hospitalization for an acute coronary syndrome  
 
Variable Meaning Exp(b) (95% CI) 
    
0_numbar No barriers to healthcare access Referent - 
1_numbar 1 barrier to healthcare access .9856506 (0.4818825, 2.016066) 
2_numbar 2 or more barriers to healthcare access 1.533045 (1.033235, 2.274632) 
    
0_grace_risk_simpl GRACE Risk Score <100 Referent - 
1_grace_risk_simpl GRACE Risk Score >= 100 to <130 3.785908 (3.283771,4.36483) 
2_grace_risk_simpl GRACE Risk Score >= 130 to <150 11.05089 (7.634646, 15.9958) 
3_grace_risk_simpl GRACE Risk Score >= 150 17.46634 (12.01679, 25.38725) 
    
0_site_cat Academic hospital – Worcester, Mass. Referent - 
1_site_cat Community hospital - Worcester, Mass. .2508362 (0.2352974, 0.2674011) 
2_site_cat Academic hospital – Macon, Georgia 1.899153 (1.610459, 2.239598) 
3_site_cat Community hospital, Atlanta, Georgia 3.015871 (2.60538, 3.491037) 
    
1_female Female .8184651 (0.4697366, 1.426087) 
0_female Male Referent - 
    
1_race_whitehisp Non-Hispanic white  1.263539 (0.8112837, 1.967906) 
0_race_whitehisp Not non-Hispanic white Referent - 
    
0_acs_trt Received percutaneous intervention Referent - 
1_acs_trt Received coronary artery bypass graft .333648 (0.0951253, 1.170256) 
1_acs_trt Received medications only 1.097179 (0.8657838, 1.390419) 
    
0_liv_sit Lives with spouse Referent - 
1_liv_sit Lives with family 1.252108 (0.789981, 1.984571) 
2_liv_sit Lives with non-family 1.493128 (1.27254, 1.751954) 
3_liv_sit Lives alone 1.160262 (0.8835349, 1.523662) 
    
1_educ_simpl Less than high school Referent - 
2_educ_simpl High school graduate .7890871 (0.5367954, 1.159955) 
3_educ_simpl Post high school / some college .7938694 (0.5141213, 1.225837) 
4_educ_simpl College graduate .5314696 (0.2664431, 1.060114) 
    
1_chd Prior diagnosis of coronary heart disease 1.383579 (0.9578369, 1.998557) 
0_chd No prior diagnosis of coronary heart disease Referent - 
    
1_ckd Prior diagnosis of chronic kidney disease 1.473686 (1.282154, 1.693829) 
0_ckd No prior diagnosis of chronic kidney disease Referent - 
    
1_pvd Prior diagnosis of peripheral vascular disease 1.890753 (1.435557, 2.490284) 
1_pvd No prior diagnosis of peripheral vascular disease Referent - 
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APPENDICES FOR CHAPTER III 
 	
Appendix 3.1: Comparisons of regression analyses for clinically meaningful declines in health-related quality of life and 
individual barriers to healthcare access among survivors of an acute coronary syndrome with and without inverse probability 
weighting 
 
 Financial Barrier to Care No Usual Source of Care Transportation Barrier 
 Yes 
(n = 305) 
No 
(n = 748) 
Yes 
(n = 149) 
No 
(n = 904) 
Yes 
(n = 92) 
No 
(n = 961) 
Relative Risks Ratios (95% CI) for 
Clinically Meaningful Decrease       
SF36v2 PCS Scores       
Unweighted       
Adjusted for Barriers Only 1.36 (1.10, 1.70) Referent 0.81 (0.59, 1.11) Referent 1.17 (0.83, 1.63) Referent 
Fully Adjusted* 1.38 (1.10, 1.72) Referent 0.87 (0.63, 1.22) Referent 1.00 (0.72, 1.39) Referent 
Weighted       
Adjusted for Barriers Only 1.36 (1.08, 1.70) Referent 0.85 (0.61, 1.18) Referent 1.24 (0.88, 1.74) Referent 
Fully Adjusted* 1.43 (1.13, 1.80) Referent 0.90 (0.65, 1.26) Referent 1.03 (0.74, 1.43) Referent 
SF36v2 MCS Scores       
Unweighted       
Adjusted for Barriers Only 1.35 (1.07, 1.69) Referent 1.11 (0.84, 1.47) Referent 1.23 (0.88, 1.71) Referent 
Fully Adjusted† 1.37 (1.08, 1.74) Referent 1.12 (0.84, 1.49) Referent 1.28 (0.91, 1.80) Referent 
Weighted       
Adjusted for Barriers Only 1.34 (1.06, 1.69) Referent 1.10 (0.82, 1.48) Referent 1.20 (0.84, 1.70) Referent 
Fully Adjusted† 1.36 (1.07, 1.75) Referent 1.12 (0.83, 1.51) Referent 1.19 (0.83, 1.71) Referent 
SAQ QOL Scores       
Unweighted       
Adjusted for Barriers Only 1.09 (0.77, 1.55) Referent 1.42 (0.96, 2.11) Referent 1.22 (0.75, 2.03) Referent 
Fully Adjusted‡ 1.07 (0.75, 1.55) Referent 1.22 (0.81, 1.82) Referent 1.08 (0.66, 1.77) Referent 
Weighted       
Adjusted for Barriers Only 1.01 (0.70, 1.46) Referent 1.69 (1.14, 2.51) Referent 1.31 (0.80, 2.17) Referent 
Fully Adjusted‡ 1.04 (0.72, 1.52) Referent 1.37 (0.92, 2.06) Referent 1.13 (0.68, 1.87) Referent 
 
* Adjusted for clinical site, age, sex, race/ethnicity, education, employment status, reperfusion therapy, GRACE risk score, 1 month SF36v2 PCS score, 1 month SF36v2 
MCS score  
† Adjusted for age, sex, race, clinical site, employment status, reperfusion therapy, 1 month SF36v2 MCS score 
‡ Adjusted for age, sex, race, clinical site, education, living situation, reperfusion therapy, GRACE risk score, 1-month SAQ QOL score, 1 month SF36v2 MCS score 
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Appendix 3.2: Comparisons of regression analyses for clinically 
meaningful declines in health-related quality of life and number of barriers 
to healthcare access among survivors of an acute coronary syndrome with 
and without inverse probability weighting 
 
 No Barriers (n = 630) 
1 Barrier 
(n = 118) 
2 or More 
Barriers 
(n = 305) 
Relative Risks Ratios (95% CI) for  
Clinically Meaningful Decrease    
SF36v2 PCS Scores    
Unweighted    
Unadjusted Referent 1.04 (0.73, 1.48) 1.38 (1.11, 1.71) 
Adjusted* Referent 1.01 (0.70, 1.47) 1.38 (1.09, 1.75) 
Weighted    
Unadjusted Referent 1.07 (0.75, 1.55) 1.41 (1.13, 1.77) 
Adjusted* Referent 1.03 (0.70, 1.51) 1.44 (1.13, 1.84) 
    
SF36v2 MCS Scores    
Unweighted    
Unadjusted Referent 1.28 (0.92, 1.76) 1.46 (1.17, 1.83) 
Adjusted† Referent 1.35 (0.97, 1.88) 1.51 (1.18, 1.93) 
Weighted    
Unadjusted Referent 1.27 (0.90, 1.80) 1.47 (1.16, 1.86) 
Adjusted† Referent 1.30 (0.91, 1.87) 1.50 (1.17, 1.93) 
    
SAQ QOL Scores    
Unweighted    
Unadjusted Referent 1.41 (0.88, 2.25) 1.23 (0.87, 1.75) 
Adjusted‡ Referent 1.06 (0.67, 1.70) 1.09 (0.74, 1.61) 
Weighted    
Unadjusted Referent 1.70 (1.06, 2.73) 1.27 (0.89, 1.83) 
Adjusted‡ Referent 1.16 (0.74, 1.83) 1.10 (0.74, 1.65) 
 
 
* Adjusted for clinical site, age, sex, race/ethnicity, education, employment status, reperfusion therapy, GRACE risk score, 
1 month SF36v2 PCS score, 1 month SF36v2 MCS score  
† Adjusted for age, sex, race, clinical site, employment status, reperfusion therapy, 1 month SF36v2 MCS score 
‡ Adjusted for age, sex, race, clinical site, education, living situation, reperfusion therapy, GRACE risk score, 1-month SAQ 
QOL score, 1 month SF36v2 MCS score 
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Appendix 3.3: Full, multivariable-adjusted model for assessing the 
relationship between individual barriers to healthcare access and clinically 
meaningful declines in physical health-related quality of life over six 
months after discharge for a hospitalization for an acute coronary 
syndrome  
 
 
Variable Meaning Exp(b) (95% CI) 
    
1_probaffordcare Financial barrier to healthcare access 1.378837 (1.100711, 1.72724) 
0_probaffordcare No financial barrier to healthcare access Referent - 
    
1_nousoc Has no usual source of care 0.8736658 (0.6254936, 1.220303) 
0_nousoc Has usual source of care Referent - 
    
1_reachingcare Transportation barrier to healthcare 0.9993246 (0.7163315, 1.394117) 
0_reaching care No transportation barrier to healthcare Referent - 
    
0_site_cat Academic hospital – Worcester, Mass. Referent - 
1_site_cat Community hospital - Worcester, Mass. 1.238218 (0.916281, 1.673268) 
2_site_cat Academic hospital – Macon, Georgia 1.205765 (0.9468777, 1.535435) 
3_site_cat Community hospital, Atlanta, Georgia 0.9200461 (0.5122202, 1.65258) 
    
0_age_cat2 59 years or less Referent - 
1_age_cat2 60 to 64 years 0.8899943 (0.6266989, 1.263908) 
2_age_cat2 65 to 69 years 0.6719675 (0.4587617, 0.9842589) 
3_age_cat2 70 to 74 years 0.6342472 (0.4134595, 0.9729357) 
4_age_cat2 75 to 79 years 0.7669496 (0.486417, 1.209275) 
5_age_cat2 80 years and older 0.6685399 (0.3768082, 1.186136) 
    
1_female Female 0.9649633 (0.7761497, 1.199709) 
0_female Male Referent - 
    
1_race_whitehisp Non-Hispanic white  0.9983472 (0.7649599, 1.30294) 
0_race_whitehisp Not non-Hispanic white Referent - 
    
0_employ_simpl2 Retired Referent - 
1_employ_simpl2 Working 0.4215867 (0.3042832, 0.5841115) 
2_employ_simpl2 Unemployed 0.7848118 (0.568958, 1.082557) 
    
1_educ_simpl Less than high school Referent - 
2_educ_simpl High school graduate 1.240019 (0.6685563, 1.236564) 
3_educ_simpl Post high school / some college 1.482076 (0.6571443, 1.226103) 
4_educ_simpl College graduate 1.116261 (0.5128056, 1.044036) 
    
0_acs_trt Received percutaneous intervention Referent - 
1_acs_trt Received coronary artery bypass graft 0.3709828 (0.2267615, 0.6069293) 
1_acs_trt Received medications only 0.9667711 (0.7449703, 1.254609) 
    
grace_risk +1 unit increase in GRACE risk score 1.007997 (1.002201, 1.013826) 
    
pcs1 +1 unit increase in 1-month PCS score 1.034708 (1.022531, 1.047029) 
    
mcs1 +1 unit increase in 1-month MCS score 0.9819731 (0.9733516, 0.990671) 
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Appendix 3.4: Full, multivariable-adjusted model for assessing the 
relationship between individual barriers to healthcare access and clinically 
meaningful declines in mental health-related quality of life over six months 
after discharge for a hospitalization for an acute coronary syndrome 
 
 
Variable Meaning Exp(b) (95% CI) 
    
1_probaffordcare Financial barrier to healthcare access 1.374199 (1.085889, 1.739057) 
0_probaffordcare No financial barrier to healthcare access Referent - 
    
1_nousoc Has no usual source of care 1.121421 (0.8436956, 1.490568) 
0_nousoc Has usual source of care Referent - 
    
1_reachingcare Transportation barrier to healthcare 1.280339 (0.9097538, 1.801881) 
0_reaching care No transportation barrier to healthcare Referent - 
    
0_site_cat Academic hospital – Worcester, Mass. Referent - 
1_site_cat Community hospital - Worcester, Mass. 1.533954 (1.138668, 2.066463) 
2_site_cat Academic hospital – Macon, Georgia 1.113063 (0.867543, 1.428067) 
3_site_cat Community hospital, Atlanta, Georgia 1.170904 (0.6870961, 1.995378) 
    
0_age_cat2 59 years or less Referent - 
1_age_cat2 60 to 64 years 0.8156995 (0.5923214, 1.123319) 
2_age_cat2 65 to 69 years 1.013679 (0.7367626, 1.394675) 
3_age_cat2 70 to 74 years 0.9252659 (0.6344435, 1.349398) 
4_age_cat2 75 to 79 years 0.9185006 (0.5697216, 1.480799) 
5_age_cat2 80 years and older 1.055797 (0.6164874, 1.808159) 
    
1_female Female 0.950185 (0.7487446, 1.20582) 
0_female Male Referent - 
    
1_race_whitehisp Non-Hispanic white  0.8774257 (0.6685857, 1.151499) 
0_race_whitehisp Not non-Hispanic white Referent - 
    
0_employ_simpl2 Retired Referent - 
1_employ_simpl2 Working 1.025094 (0.7638654, 1.375659) 
2_employ_simpl2 Unemployed 1.746066 (1.260303, 2.419057) 
    
0_acs_trt Received percutaneous intervention Referent - 
1_acs_trt Received coronary artery bypass graft 0.937827 (0.6692346, 1.314217) 
1_acs_trt Received medications only 1.008047 (0.7632031, 1.331439) 
    
mcs1 +1 unit increase in 1-month MCS score 1.045743 (1.032458, 1.059198) 
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Appendix 3.5: Full, multivariable-adjusted model for assessing the 
relationship between individual barriers to healthcare access and clinically 
meaningful declines in disease-specific health-related quality of life over 
six months after discharge for a hospitalization for an acute coronary 
syndrome 
 
 
Variable Meaning Exp(b) (95% CI) 
    
1_probaffordcare Financial barrier to healthcare access 1.070771 (0.7461753, 1.536571) 
0_probaffordcare No financial barrier to healthcare access Referent - 
    
1_nousoc Has no usual source of care 1.216192 (0.8116667, 1.822327) 
0_nousoc Has usual source of care Referent - 
    
1_reachingcare Transportation barrier to healthcare 1.079925 (0.6584914, 1.771077) 
0_reaching care No transportation barrier to healthcare Referent  
    
0_site_cat Academic hospital – Worcester, Mass. Referent - 
1_site_cat Community hospital - Worcester, Mass. 1.155978 (0.7125471, 1.875363) 
2_site_cat Academic hospital – Macon, Georgia 1.172866 (0.8068508, 1.704919) 
3_site_cat Community hospital, Atlanta, Georgia 0.9823956 (0.3697766, 2.609957) 
    
0_age_cat2 59 years or less Referent - 
1_age_cat2 60 to 64 years 0.7584606 (0.450193, 1.277813) 
2_age_cat2 65 to 69 years 0.6027267 (0.3317696, 1.094975) 
3_age_cat2 70 to 74 years 0.9656705 (0.54239, 1.719279) 
4_age_cat2 75 to 79 years 1.051236 (0.526339, 2.099593) 
5_age_cat2 80 years and older 1.045568 (0.4606631, 2.373126) 
    
1_female Female 0.9884023 (0.697647, 1.400334) 
0_female Male Referent - 
    
0_race_whitehisp Not non-Hispanic white Referent - 
1_race_whitehisp Non-Hispanic white  0.7318881 (0.4925264, 1.087577) 
    
0_liv_sit Lives with spouse Referent - 
1_liv_sit Lives with family 1.557629 (0.9918378, 2.446173) 
2_liv_sit Lives with non-family 1.754823 (1.124744, 2.737873) 
3_liv_sit Lives alone 1.433053 (0.9358127, 2.1945) 
    
1_educ_simpl Less than high school Referent - 
2_educ_simpl High school graduate 0.6982796 (0.4493237, 1.085174) 
3_educ_simpl Post high school / some college 0.5903039 (0.3667695, 0.9500755) 
4_educ_simpl College graduate 0.6579102 (0.3933127, 1.100513) 
    
0_acs_trt Received percutaneous intervention Referent - 
1_acs_trt Received coronary artery bypass graft 0.6767451 (0.389332, 1.176333) 
1_acs_trt Received medications only 1.058712 (0.6784421, 1.652124) 
    
0_smoke Non-smoker Referent - 
1_smoke Former smoker 1.28699 (0.8531865, 1.941362) 
2_smoke Current smoker 1.636896 (1.01178, 2.648233) 
    
grace_risk +1 unit increase in GRACE risk score 1.001355 (0.9920978, 1.010698) 
    
saql1 +1 unit increase in 1-month SAQ QOL 
score 
0.9696647 (0.9560534, .9834698) 
    
mcs1 +1 unit increase in 1-month MCS score 1.028523 (1.019876, 1.037243 
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Appendix 3.6: Full, multivariable-adjusted model for assessing the 
relationship between number of barriers to healthcare access and clinically 
meaningful declines in physical health-related quality of life over six 
months after discharge for a hospitalization for an acute coronary 
syndrome 
 
 
Variable Meaning Exp(b) (95% CI) 
    
0_numbar No barriers Referent - 
1_numbar 1 barrier 1.011338 (0.6956837, 1.470214) 
2_numbar 2 or more barriers 1.382 (1.089038, 1.753773) 
    
0_site_cat Academic hospital – Worcester, Mass. Referent - 
1_site_cat Community hospital - Worcester, Mass. 1.254941 (0.9302359, 1.692988) 
2_site_cat Academic hospital – Macon, Georgia 1.212704 (0.9513728, 1.545821) 
3_site_cat Community hospital, Atlanta, Georgia 0.937311 (0.5236719, 1.677676) 
    
0_age_cat2 59 years or less Referent - 
1_age_cat2 60 to 64 years 0.9002778 (0.6356024, 1.275168) 
2_age_cat2 65 to 69 years 0.6785938 (0.4636227, 0.9932421) 
3_age_cat2 70 to 74 years 0.6420769 (0.4195335, 0.9826693) 
4_age_cat2 75 to 79 years 0.7790289 (0.4939586, 1.228617) 
5_age_cat2 80 years and older 0.6668483 (0.3762447, 1.181908) 
    
1_female Female 0.9726317 (0.782176, 1.209463) 
0_female Male Referent - 
    
1_race_whitehisp Non-Hispanic white  1.007552 (0.7712673, 1.316224) 
0_race_whitehisp Not non-Hispanic white Referent - 
    
0_employ_simpl2 Retired Referent - 
1_employ_simpl2 Working 0.4180692 (0.3016958, 0.5793315) 
2_employ_simpl2 Unemployed 0.7790021 (0.5668385, 1.070577) 
    
1_educ_simpl Less than high school Referent - 
2_educ_simpl High school graduate 0.9117718 (0.6715024, 1.238012) 
3_educ_simpl Post high school / some college 0.9086419 (0.6651375, 1.241292) 
4_educ_simpl College graduate 0.7431636 (0.5211383, 1.05978) 
    
0_acs_trt Received percutaneous intervention Referent - 
1_acs_trt Received coronary artery bypass graft 0.3675486 (0.2246894, 0.6012389) 
1_acs_trt Received medications only 0.9613726 (0.740693, 1.247801) 
    
grace_risk +1 unit increase in GRACE risk score 1.008044 (1.002272, 1.01385) 
    
pcs1 +1 unit increase in 1-month PCS score 1.035052 (1.022889, 1.04736) 
    
mcs1 +1 unit increase in 1-month MCS score 0.9823695 (0.9737303, 0.9910854) 
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Appendix 3.7: Full, multivariable-adjusted model for assessing the 
relationship between number of barriers to healthcare access and clinically 
meaningful declines in mental health-related quality of life over six months 
after discharge for a hospitalization for an acute coronary syndrome 
 
Variable Meaning Exp(b) (95% CI) 
    
0_numbar No barriers Referent - 
1_numbar 1 barrier 1.351852 (0.9698907, 1.884236) 
2_numbar 2 or more barriers 1.510399 (1.180608, 1.932313) 
    
0_site_cat Academic hospital – Worcester, Mass. Referent - 
1_site_cat Community hospital - Worcester, Mass. 1.538755 (1.142964, 2.071604) 
2_site_cat Academic hospital – Macon, Georgia 1.11461 (0.8687304, 1.430081) 
3_site_cat Community hospital, Atlanta, Georgia 1.179623 (0.6962444, 1.998595) 
    
0_age_cat2 59 years or less Referent - 
1_age_cat2 60 to 64 years 0.8038264 (0.5843749, 1.105689) 
2_age_cat2 65 to 69 years 1.017136 (0.7373085, 1.403165) 
3_age_cat2 70 to 74 years 0.9513129 (0.6532811, 1.385309) 
4_age_cat2 75 to 79 years 0.9298088 (0.5780703, 1.49557) 
5_age_cat2 80 years and older 1.062801 (0.6204983, 1.820387) 
    
1_female Female 0.9457558 (0.7473751, 1.196794) 
0_female Male Referent - 
    
0_race_whitehisp Not non-Hispanic white Referent - 
1_race_whitehisp Non-Hispanic white  0.8760787 (0.6697, 1.146056) 
    
0_employ_simpl2 Retired Referent - 
1_employ_simpl2 Working 1.017426 (0.7595919, 1.362779) 
2_employ_simpl2 Unemployed 1.781731 (1.289444, 2.461964) 
    
0_acs_trt Received percutaneous intervention Referent - 
1_acs_trt Received coronary artery bypass graft 0.9407935 (0.6714274, 1.318225) 
1_acs_trt Received medications only 0.9898801 (0.7484282, 1.309227) 
    
mcs1 +1 unit increase in 1-month MCS score 1.045267 (1.032061, 1.058643) 
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Appendix 3.8: Full, multivariable-adjusted model for assessing the 
relationship between number of barriers to healthcare access and clinically 
meaningful declines in mental health-related quality of life over six months 
after discharge for a hospitalization for an acute coronary syndrome 
 
 
Variable Meaning Exp(b) (95% CI) 
    
0_numbar No barriers Referent - 
1_numbar 1 barrier 1.063874 (0.6683424, 1.693485) 
2_numbar 2 or more barriers 1.093767 (0.7443806, 1.607142) 
    
0_site_cat Academic hospital – Worcester, Mass. Referent - 
1_site_cat Community hospital - Worcester, Mass. 1.132788 (0.6883433, 1.8642) 
2_site_cat Academic hospital – Macon, Georgia 1.147093 (0.7800669, 1.686808) 
3_site_cat Community hospital, Atlanta, Georgia 0.939973 (0.3496723, 2.526792) 
    
0_age_cat2 59 years or less Referent - 
1_age_cat2 60 to 64 years 0.7461162 (0.4406044, 1.263467) 
2_age_cat2 65 to 69 years 0.5974644 (0.3298012, 1.08236) 
3_age_cat2 70 to 74 years 0.9472681 (0.5325906, 1.684816) 
4_age_cat2 75 to 79 years 1.019932 (0.5076534, 2.049157) 
5_age_cat2 80 years and older 1.032218 (0.4509289, 2.362843) 
    
1_female Female 0.9771188 (0.6902028, 1.383305) 
0_female Male Referent - 
    
0_race_whitehisp Not non-Hispanic white Referent - 
1_race_whitehisp Non-Hispanic white  0.7150626 (0.4803908, 1.064372) 
    
0_liv_sit Lives with spouse Referent - 
1_liv_sit Lives with family 1.577208 (1.006227, 2.472191) 
2_liv_sit Lives with non-family 1.760828 (1.125071, 2.75584) 
3_liv_sit Lives alone 1.438295 (0.9368821, 2.208061) 
    
1_educ_simpl Less than high school Referent - 
2_educ_simpl High school graduate 0.6896708 (0.4415009, 1.077338) 
3_educ_simpl Post high school / some college 0.5788523 (0.3577321, 0.9366504) 
4_educ_simpl College graduate 0.635258 (0.635258, 1.060499) 
    
0_acs_trt Received percutaneous intervention Referent - 
1_acs_trt Received coronary artery bypass graft 0.6887923 (0.3922292,	1.209586) 
1_acs_trt Received medications only 1.057779 (0.6760328, 1.655092) 
    
0_smoke Non-smoker Referent - 
1_smoke Former smoker 1.28699 (0.8488451,	1.936061) 
2_smoke Current smoker 1.636896 (1.012507, 2.648601) 
    
grace_risk +1 unit increase in GRACE risk score 1.00142 (0.9921814, 1.010744) 
    
saql1 +1 unit increase in 1-month SAQ QOL 
score 
1.028075 (1.01955, 1.036671) 
    
mcs1 +1 unit increase in 1-month MCS score 0.9696356 (0.9558318, .9836388) 
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